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A B S T R A C T 
1. Administration of 3-hyaroxy-3-raethylglutaric acid (1*13) 
for one week to normally-fad rabbits caussd signif icant 
lowering of serum total* astari f led and free cholesterol* 
total phospholipids and tr iglycerides . Serum ly s o l e d thin, 
l ec i th in , sphingomyelin and cephallns a lso decreased. 
2. in hypercholesterolemia rabbits returned to a normal diet* 
two week's administration of IMS caused a gradual decrease 
in serum cholesterol and phospholipids over th i s period* 
The serum triglycerides leve l and aort ic l i p i d concen-
trations were markedly lowered at the end of th i s two 
week's treatment, serum cephalins and other phospholipids 
were a lso lowered in these animals. 
3. simultaneous administration of H43 and feeding the 
atherogenic diet for 54 days prevented the r i se in serum 
cholesterol and phospholipid l eve l s . Triglyceride l eve l s 
in serum, l i v e r and aorta were s ignif icantly reduced, 
serum cephallns substantially decreased, while cardiolipln 
almost disappeared. Aortic lyso lec l th in , l ec i th in , 
cephallns and cardiolipln a lso decreased in these animals. 
*• IS, vitro IMS caused a marked decrease in rat hepatic malic 
enzyme act iv i ty (3590, while NADP-lsocltric dehydrogenase 
and malic dehydrogenase were s ignif icantly increased by 
20 and 18% • respectively, However, iM3 had no in vitro 
effect on glucoae-6-phosphate dehydrogenase and l a c t i c 
dehydrogenase ac t iv i ty . Inhibition of malic enzyme seems 
to be a l l o s t e r i c both with the crude as* purified enzyme 
preparations. T*e concentration of rt*3 required for 
50% inhibit ion was i9 .2x lO"V 
Administration of IMS to normally-fed rats for one week 
caused s ignif icant decrease in the a c t i v i t i e s of malic 
enzyme and glucose-6-phosphate dehydrogenase by 25 and 
19%, respectively. Lactic dehydrogenase and *JAJ*-isocitric 
dehydrogenase a c t i v i t i e s were a lso s ignif icantly increased 
but there was no in. vivo e f fect of H*3 on malic dehydro-
genase ac t iv i ty . 
whan UV3 treatment was extended to 5% cholesterol-fed rats 
for one week* a pronounced increase in the act iv i ty of 
malic enzyme (85%), glucose-6-phosphate dehydrogenase(53%), 
l a c t i c dehydrogenase (60%) and malic dehydrogenase(25%) 
was observed. However, a l i t t l e but s ignif icant increase 
(11%) was recorded in NADP-lsocitric dehydrogenase act iv i ty . 
ma treatment to the fasting rats (48 hr) significantly 
increased the a c t i v i t i e s of malic enzyme, glucose-6-phosphate 
dehydrogenase and NAJDP-isocitric dehydrogenase by 57,42 
and 15%, respectively, However* EMS had no signif icant 
ef fect on malic dehydrogenase and l a c t i c dehydrogenase 
under these conditions. 
In fasted (48 hr), fat free diet-refed (48 hr) rats* the 
act iv i ty of malic enzyme and glucose-6~phosphate dehydrogenase 
was increased. This increase was inhibited in #1S-treated 
animals by 32* in case of former and 42* in the la t ter . Under 
similar conditions » » did not significantly af fect the 
a c t i v i t i e s of l a c t i c dehydrogenase* malic dehydrogenase and 
WAUP-isocitric dehydrogenase. 
in « « - t r e a t e d normally-fed rats* the incorporation of 
acetate- 1-C into hepatic fatty acids was increased by 120*. 
This indicated an increased fatty acid synthesis. However, 
under these conditions malic ensyme and glucose-6-phosphate 
dehydrogenase a c t i v i t i e s were lowered which i s an incompre-
hensible biochemical e f fec t of H4Q. 
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!• I J L T a o p u e T i o a 
r 
Atherosclerosis and UPld Metabolism - in the l a s t few 
decades concerted ef forts have been made by Biochemists* 
Pathologists, Nutritionists* Clinicians and internists to 
investigate the role of various hypocholesteroleraic agents, 
in combating hypercholesterolemia and atherosclerosis* 
Atherosclerosis and a l l i e d diseases related to hyper-
cholesterolemia and hyperlipemia are major medical problems 
of the modern age* since i t i s believed tnat hypercholes-
terolemia and hyperlipemia are prelude to atherosclerosis, 
the compounds capable of correction of these two abnormalities 
are considered to be of paramount importance and help in the 
chemotherapy of atherosclerosis . 
The modern name of the disease "Atherosclerosis" i s 
derived from two Greek words* 'ether*** meaning "porridge" 
or "mush" and ' sc leros ' meaning "hard". This apparently 
contradictory combination describes the fact that the lesion 
begins as a so f t deposit and hardens as i t ages, however, 
the terra "Atherosclerosis" has a variety of meaning depending 
upon the approach to the problem, for Internists* the 
diagnosis consists of certain spec i f ic signs and symptoms 
that indicate tne disease, for a Pathologist, a person has 
atherosclerosis i f a variable combination of changes in intima 
of arter ies involving local accumulation of lipids* complex 
carbohydrates* blooct and i t s coagulation products* fibrous 
t i s sue and calcium deposits are present which nay be associated 
with c l in i ca l synitons. Biorck (1965) explained the tern in 
many ways in c l in i ca l stuaies . In h i s opinions 
""Ahe terra fatty atretic or spot i s applied to superficial 
yellowish grey intiraal lesions* which are stained se lect ively 
by fa t s ta ins . It i s not synonymous with 'atheroma*. H 
"The term 'fibrous plaque' i s applied to a circumscribed* 
elevated lntimal thickening which i s firm* and grey or pearly 
white. • 
The term 'atheroma* i s applied to an atherosclerotic 
plaque in which fatty softening i s predominant, complicated 
les ions are defined as les ions with additional changes or 
a l terat ions such as haemorrhage* thrombosis* ulceration and 
calcareous deposits. " 
Hence* for c l in ic ians atherosclerosis encompasses a 
wide variety of c l i n i c a l e n t i t i e s which may include myocardial 
infarction* angina pectoris* cerebro-vascular diseases and 
occasionally changes which can be detected only on an 
Electrocardiogram, conclusively* atherosclerosis i s a complex 
and multi faceted condition which may be a col lect ion of 
pathological s tates with overlapping s imi lar i t i e s of arter ia l 
abnormalities. Generally* atherosclerosis either of the 
aorta or coronary arter ies involves the formation of l ip id 
deposits inside the walls of blood vesse ls . These fatty 
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substances appear mainly in smooth muscle cells and foam 
cells within the arterial linings. In the spaces between 
the cells small amounts of cholesterol can be detected. 
Very fine fibers of a material which behaves like fibrin 
also show up within the lining as well as on its surface. 
At this early stage the forerunner of atherosclerotic 
lesion can be recognized in the form of fatty streaks. It 
is believed that 90% of all genuine forms of angina pectoris 
and myocardial infarction are associated with sclerotic 
changes in coronary artery (schettler, 1961). Arteries 
afflicted with atherosclerosis exhibit thickening of the 
arterial wall intime, usually hypertrophy of the media with 
clearly demonstrable lipid deposits. Since all these 
factors lead to decrease in the sise of the arterial lumen, 
it results in restriction of flow of blood at reasonable 
pressures. Thus the restricted supply of oxygen and 
nutrients to coronary muscle leads to diminished performance 
and finally heart failures. 
Many factors* that are suspected of contributing to 
atherosclerosis have been investigated. Undoubtedly heredity 
is an important factor. This includes marked-obesity* hyper-tensta 
(diastolic blood pressure of 95 mm or above), "inborn errors" 
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of hyperlipidemia and hypercholesterolemia (serum cholesterol 
260 rag% or above), diabetes, aeranged thyroid functions/ 
malfunction of the adrenals and many others. Environmental 
factors may be of primary or secondary influence; these 
include emotional s tress s i tuat ions , ulet, climate, detrimental 
hahbits (smoking, lack of exercise e t c ) , contracted diseases, 
certain drugs, and other metabolic disorders such as elevated 
serum uric acid (Montoye e t a l . , 1967; Beneaek, 1967), lowered 
serum albumin (tfashev e t a l . , 1967), lowered lipoprotein 
l ipase (Petrova, 1967) and lowered endogenous heparin (Va 11 oan, 
1967), e tc . At present, no single factor can be exclusively 
i solated in the etiology of coronary atherosclerosis . High 
blood pressure, no doubt, i s a serious contributor to the 
atherosclerosis elongwith hypercholesterolemia. Diabetes, In 
combination with hypertension, i s a l so a crucial factor 
responsible for the development of the lesion (Robertson, 1962). 
Recently epidemiological aspects of atherosclerosis 
have been reviewed (Epstein, 1971). Accordingly, serum 
cholesterol l e v e l s are generally low in Inola but in recent 
years these may have been ris ing. Hypertension i s probably 
the commonest of a l l cardiovascular disorders in the African 
continent and Western countries. In India, high blood pressure 
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i s frequent among patients with ischemic disease* In India, 
as would be expected in a vest country with many populations 
differing in origin and l iving conditions/ wide variations 
in the frequency of coronary disease have been reported. It 
i s quite unexpected and unexplained to find the prevalence 
of coronary disease in cftandigarh, the capital city of 
Punjab, as high as in the United States. These studies suggest 
taat culture and customs are related to prevalence of the 
disease. In general* coronary disease i s l e s s frequent in 
India than in more affluent s o c i e t i e s . 
Besides heredity factors, dietary factors are numerous 
and studies to produce variations in serum cholesterol level 
are even more p lent i fu l especial ly in animals. schonebecK 
e t a l . (1962) concluded that two factors are responsible 
for the development of atherosclerosis* one i s located in 
serum and the other in the arter ia l wall. According to 
Ursprung (1965*66) cholesterol plays a major role in the 
development of atherosclerosis , I&idemiolcgical studies in 
man suggested that high fa t diet with or without cholesterol 
plays a major role in the development of atheromata. I t i s 
important to remember tnat the correlation between cholesterol 
l eve l and heart disease* although soundly based* i s s ta t i s t i c s , 
and that there i s ye t no antemortem* diagnostic t e s t for this 
disease. 
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Cholesterol i s a major constituent of atherosclerotic 
l es ions (Frantz and Moore, 1969) and the routine method of 
producing atherosclerosis in experimental animals i s by 
feeding cholesterol a t l eve l s of 0,5-5% by weight of the 
d iet (Kritchevsky, 1964; constantinioes, 1965). Cholesterol 
with added fats and o i l s in the diet nas been found more 
atherogenic than alone. Kritchevsky e£ aJL. (1961) showed that 
cholesterol produces atheromatous plaque in rabbits when 
suspended in corn o i l . These workers further noted that 
cholesterol in heated corn o i l i s more atherogenic. This 
could be due to the presence of higher concentration of free 
fatty acids in heated corn o i l (Kritchevsky and Tapper, 1962). 
I t has been found that saturated fats along with cholesterol 
produce more severe atheroma than unsaturated fats 
(Kritchevsky and Tepper, 1967a). Therefore, cholesterol and 
most probably fatty acids are inevitable suspects, because 
the formation of the atherosclerotic lesion i s essential ly 
an inflammatory response to these parameters. It i s of 
in teres t to note that af ter prolonged cholesterol feeaing, a 
slow f a l l in the cholesterolemla i s observed with an increase 
in the severity of the pre-established atheromatous les ions 
(Mc Mi 11 an e t aj . . , 1955; Kritchevsky and Tapper* 1961). This 
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i s due to the fact that fatty plaque becomes f lbrot lc and 
begins to resemble the advanced human lesion(coastantinides 
e t a l . , 1960). These observations have been confirmed in 
rabbits as wel l (Bailey aud Butler, 1967; Kritchevslcy and 
Tepper, 1967b). babbits receiving corn o i l and coconut o i l 
diets (no added cholesterol) alternately, or as a 50 s 50 
mixture, for 10s 10 week periods, developed more aort ic and 
coronary atherosclerotic les ions on the alternate regimen 
tnan on the 50s50 mixture (v ies and Jtloeze, 1967). without 
added cholesterol in the diet , few atheroma are found 
(Conner e£ a l . , 1967). Or*sham and rtovard (I960) found that 
rats developed atnerosclerosis when fed a d iet containing 
cholesterol, chol ic acid, thiouracil and peanut o i l . .recently 
*ritchevsky e t a l . 11971) have reported that the rabbits fed 
a d iet containing coconut or peanut o i l with 2% cholesterol 
had the most extensive, as well as the most frequent and 
severe, les ions than that of corn o i l or special fat fed 
rabbits. Recently much more severe atherosclerosis was 
developed in hypercholesterolemia baboons by an immunological 
injury (Howard e t a l . , 1971). 
Mechanism of Envelopment of Atheroscleroses - Ihe deposition 
of l i p i d s in arter ies or the atheroma formation i s a 
complicated process which i s not easy to explain.Pathologists 
8 
have been puzzled about the factors responsible for the 
progression of atherosclerosis . There are two prevalent 
concepts on the genesis of atheromatous Plaques* the 
f i l t ra t ion theory ana tne tnrombogenic theory. The/involve 
different mechanisms and are not easi ly reconcilable, she 
f i l t ra t ion theory presumes that Plasma constituents enter 
directly into the arter ia l wall by a process of diffusion 
from the lumenal surface of the vessel , injury to the 
endothelium and/or in time or a high l eve l of lipoprotein 
encourages plaque formation, court! ce and Gar l i ck (1962) 
reported that serum lipoprotein f i r s t passes across the 
endothelial va i l , but Z3-lipoprotein fraction may become 
held up in the subendothelial space end hence get deposited. 
I t has become necessary* therefore, to postulate that either 
l ipoproteins are altered in some way during the process of 
deposition or the l i p i d deposits ar ise in part by the 
synthesis in the arter ia l wall. 
According to throrabogenic theory, mural thrombi adhere 
to the lumenal surface end become incorporated into the wall 
by an overgrowth of endothelium. Ihe type of plaque formed 
i s dependent upon the ratio of the adhering materials, 
p la te l e t s and f ibrin. It has been shown that macrophages 
a l s o play an important role in deposition and removal of 
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l i p i d s in atherosclerosis . Lipid removal nay be a c r i t i c a l 
factor (Adams, 1969) in pi aqua formation and the location of 
lec i th in-cholesterol transacylase in the arter ia l wall 
(Abdullah e t ajl,, 1969) could play an important role, since 
cholesterol l a rapidly exchanged (Smith, 1969) with the 
blood while cholesterol ester i s not. lay (1964) has 
suggested four possible ways for the deposition process 
with macrophages* (a) by the uptake of l i p i d or lipoprotein 
by macrophages in the lesion (b) by the subsequent metabolism 
of such ingested l i p i d or (c) by primary synthesis of l ip ids 
by macrophages which have accumulated in the vic inity of the 
i u i t i a l les ion; and (d) alternatively macrophages may ingest 
l i p i d at some s i t e distant from the artery and carry i t into 
the arter ia l wall. 
There are several possible ways to explain the 
pathogenetic patterns of atherosclerosis caused by the 
various food fa t s . Che poss ib i l i t y i s that some types of 
the l i p i d may be metabolized more ef fect ively by the l iver 
and the artery walls than others As shown in peanut o i l 
fed rabbits, a greater gastrointest inal absorption of aietary 
cholesterol or a re lat ively retarded catabolism of the 
exogenous cholesterol may be associated with the consistent 
accumulation of aorta l ip ids (Kxltchevsky e t « 1 . , 1971). 
A further poss ib i l i ty i s that some types of l ip ids when 
deposited within c e i l s of the aort ic wall nay leag to a 
mora severe metabolic reaction than others. This reaction 
i s probably a t l ea s t partly responsible for the character-
i s t i c morphology of the les ions , some aspects of t r ig ly -
ceride structure must a l so be important to cholesterol 
absorption, transport and deposition. Few evidence a lso 
indicate th t relat ively l i t t l e lipoprotein penetrates from 
whereas 
the lumen into the normal rabbit aorta, /entry from lumen i s 
very substantially augmented when the endothelium end intima 
become more permeable in severe atheroma (Adams e t a l . ,1970). 
These observations indicated that l i t t l e cholesterol enters 
the inner layers of the normal aort ic wallas lipoprotein, 
but in severe atheroma direct plasma leak into the wall from 
the lumen would allow cholesterol to enter in lipoprotein 
form. Day (1962) showed that in early and advanced lesions 
the distribution of phospholipids was similar to those of 
cholesterol and neutral l ip ids but after few weeks cholesterol 
l eve l diminished, however, phospholipid remained distributed 
intra ce l lu le rly in macrophages scattered throughout the newfy 
organized les ions . 
in the coronary diseased groups, both cholesterol and 
phospholipids were increased in the serum, but the cholestero 
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phospholipid* (C/P) r a t i o was l ikewise increased, «8iis 
indicated that the r i se in phospholipids had not kept pace 
with that of cholesterol , i t i s suggested that factors 
favouring the deposition of cholesterol in the in time are 
enhanced because of the lack of su f f i c i ent phospholipid to 
ac t as a co l lo id s tab i l i s er . Pesters •£ «£. (1970) a lso 
believed that the structure of phospholipids may play a 
role in the s t a b i l i t y of l ipoproteins and their interaction 
with the arter ia l wall, since the cholesterol to phospho-
l i p i d s rat io i s generally believed to be an index of a there-
gene c i ty , the r i se in c/P in the />- l ipoprote ins i s a 
pre-requisite for atherogenecity (Gresham e t a l . , 1965). 
A correlation between elevated serum triglyceride and 
cholesterol l eve l s has been shown (Feldman and *allace, 1964}. 
Tha aortas of the human and most of the experimental animals 
are capable of synthesizing come of these l ip ids which 
accumulate in the atherosclerotic l es ions (Stein and stein, 
1962; Loonwijer e t a l . , 1962). Le of land e t a l . (1965) showed 
that in pigeon the coronary disease i s characterized by the 
accumulation of various l i p i d s especial ly of sterol esters 
and free s tero l . In the l a t t e r stages as the aorta becomes 
relat ively more diseased, the synthesis of fatty acids i s 
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enhanced in aorta. The atherosclerotic plaque itself 
appears to ba tha chief site of this synthesis. Likewise, 
as tha aorta becomes more diseased,, relatively mora of 
tha newly synthesize a fatty acids become estarified to 
cholesterol. Mewman et aJL. (1968) showed the incorporation 
of fatty acids into aortic cholesterol astara in cholesterol-
fed animals. They also demonstrated that serum fatty acids 
penetrate rapidly than cholesterol to tha aita of aatrification 
in arteries. Tha exact mechanism by which cholesterol aatars 
accumulate in tha arterial wall has not so far been elucidated. 
Clements and coworkers (1969) have shown tha presence in 
aorta of aldose reductase, an enzyme which they feel provides 
a mechanism for the alteration of arterial metabolism by 
hyperglycemia. Another approach to molecular interactions 
was described by Levy and Day (1969) who concluded from their 
results that the low density lipoproteins are uniquely 
polycationic at the surface and that these ions react with 
the internal arterial macromolecular poly anions. 
High concentrations of sphingomyelin have been shown 
in the aortas and plasmas in experimental monkeys than those 
of normal monkeys (Portman and Alexander, 1970), increased 
•i f'1! 
rates of synthesis and of uptake from plasma of sphingomyelin 
may account for the increased concentrations of sphingomyelin 
in the a t e r o s c l e r o t i c arteries* even though the abi l i ty to 
degrade sphingomyelin i s a lso enhanced in the atherosclerotic 
aorta, i n i s might be due to synthesis* catabolism and 
endothelial uptake from* or exchange with the plasma 
lipoproteins, recently elevated proportions of phosphatidyl 
ethanolamine were found to be more closely connected witft 
the occurence of peripheral occlusive ar ter ia l disease than 
any other of plasma l i p i d and phospholipid parameters, and 
hence plasma phosphatidyl ethanolamine i s bet ter indicator 
in the predictabi l i ty of atherosclerotic complications 
(kuns and Stummvoll, 1971). 
some Important aypocholesterolemic and Hypolipidemic Agenta-
It i s clear from the previous discussions that 
atherosclerosis can not be explained in terms of cholesterol 
alone* although i t has been implicated in the etiology of 
atherosclerosis in animals and man. certainly., cholesterol 
i s one of the causative factor which i s amenable to control 
by dietary means or by administration of drugs. Because 
cholesterol i s the principal component of the atheromatous 
plaque* measures to reduce the leve l of cholesterol in the 
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blood by drug therapy can reasonably be expected to prevent, 
or a t l e a s t retard the development of atherosclerosis . At 
present the prevailing therapeutic approach to atherosclerosis 
focuses on the treatment of hyperlipldemia* hypertension, 
obesity, ui abet as and otner associated pathologies, uiet i s 
one of the most Important factors in the prophylaxis of 
atherosclerosis . After the disease has manifested i t s e l f , 
d ie t control i s usually a mandatory part of the therapeutic 
regimen. Generally, d iets are directed toward the reduction 
of obesity and replacement of meat and saturated fat products 
with food containing unsaturated fats and non-meat high 
protein substances (Christaids and Hinder, 1969). If food 
management does not lower serum l i p i d s suff ic ient ly the l eve l s 
may be decreased further by administration of hypolipidemic 
drugs, tfovedays drug use has centred on compounds or 
substances that wi l l lower spec i f ic serum l ip ids , notably 
cholesterol and/or tr ig lycerides . There are two major 
indications for the lowering of serum l ip ids . One i s the 
reduction of severe hyperlipidemia to (a) prevent l ip id 
deposits I xanthoma ta) and (bj elimination of abdominal pain 
and pancreatia due to high l i p i d l e v e l s . The otner rationale 
to reduce serum l i p i d s i s that lowering of these blooo 
constituents w i l l lessen the l ikel ihood of coronary heart 
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disease and atherosclerosis risk. There are three main 
possible ways toy which most of the cholesterol inhibitors 
nay e f fect hypercholesterolemia and hyperlipemias 
(I) stimulation of cholesterol catabolisra and excretion 
(II) inhibition of cholesterol absorption and reabsorption 
( i l l ) inhibit ion of i t s endogenous synthesis. 
Administration of large doses of n icot in ic acid has 
been shown to exhibit protective action on hypercholes-
terolemia and l ip id deposition in aorta of cholesterol .fed 
rabbits (Altschul e& a l . , 1955; Altschul and Hoffer, 1955). 
Later investigations have shown that i t a l so reduced the 
tr iglyceride, phospholipid and free fatty acid (FFA) contents 
of the blood, together with the leve l of />- l ipoprote ins 
(Altschul, 1964). I t has been suggested that n icot in ic acid 
may act prior to the formation of mevalonic acid (MVA) 
(Gamble end weight, 1961). Carlson e t a l . (1968) shoved 
that administration of lg n ico t in ic acid per day for f ive 
days decreased plasma triglycerides , cholesterol and 
phospholipids in hyperllporoteinemic patients . It was 
proposed that n icot in ic acid inhibited mobilisation of free 
fatty acids from adipose t i s sues . This reduced the uptake 
of free fatty a d d s in l iver , which resulted in decreased 
hepatic formation of very low density lipoprotein (VLOJP). 
The consequences of these event* would be reduced con version 
of VLULP to LDLP and eventually diminution of i*DM> leve l in 
p lasm; thus plasma cholesterol and phospholipids would be 
lowered. 
Many derivatives of n icot in ic acid were shown to 
reduce the serun l ip ids without definite s ide e f fects 
(Tribiano end Spencer, 1962). Blanco et a l . (1963) showed 
that coraplarain a derivative of niacin, decreased blood 
cholesterol as well as other l ip ids . It was shown that 
administration of dl-X-tocopheryl nicotlnate, in hyper-
cholesterolemia subjects caused decrease in serum total 
cholesterol with improvement of the subjective symptoms 
(Wakasa e t a 1. ,1966). Among nicot inic , nicotinuric and 
3-pyridin ace t i c acids (100 mg - 250 mg/kg) given intra-
peritoneal ly to hyperlipideraic and hypercholesterolemia rats 
nicotinuric acid was found to be most e f fec t ive (Brus, 1967). 
Further, a new derivative 2, 2,6,6-tetraJti8(nicotinoyloxy-
methyl) cyclohexanol (iC-31) has been reported as hypo-
cholesterolemic agent (Aso e t a l . ,1969). &»31 supreased the 
elevation of serum cholesterol , phospholipid and triglyceride 
only 
l e v e l s but depressed the accumulation o f / t o t a l cholesterol 
and phospholipids in l iver . ine feypocholesterolemic action 
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of it-31 may be due to inhibit ion of exogenous sterol 
absorption. Recently, Barborlac and Meade (1971) showed 
reduction of usual alcohol-induced enhancement of alimentary 
lipemia in man by n icot in ic acid administration, similar 
resul ts ware obtained in rats a l so when they were fed a corn 
o i l -a lcohol mixture in the diet . Under these conditions 
l e s s incorporation of the C- label led dietary fa t into 
plasma tr iglycerides was observed. Another new derivative 
of n icot in ic acid, pentraerythrltolteCtranicotinate (PJSMI) 
has been shown to possess hypolipidemic properties in high 
fat-high cholesterol fed rabbits (Brattsand and Lundholm, 1971). 
They showed that P«CH reduced the increase of free and 
e s t r i f l e d cholesterol and t r i g l y c e r i d e s in serum. PfiTti 
appeared generally to be somewhat more e f fect ive than 
n icot in ic a d d in reducing l i p i d Inf i l trated area of the 
aorta. 
Pui^g-Muset e t a l . (1960) showed a marked reduction of 
blood cholesterol in humans as well as in experimental animals 
when an enzyme hepatocatalase was Intramuscularly injected. 
The s i t e of inhibit ion of th i s compound was believed to be 
between MVA and squalene (Caravaoa e£ a l . #1963). I t has no 
s ignif icant e f fect on blood triglycerides and phospholipids. 
Recently, an act ive peroxidase , subunit of the hepatocatalase 
markedly prevented cholesterol induced hypercholesterolemia 
and a l so l i p i d s accumulation in l iver , heart aed aorta 
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In rabbits without any toxic i ty and undesirable side 
e f fects (Caravaca at al.. ,1967). i t a l s o decreased the serum 
turbidity. 
Blohm at a l . (1959) showed that triparanol (Mfift-29) 
lowared serum and l ivar cholesterol 1 avals, with concomitant 
accumulation of oeraosterol. ue-Olivoire (1964) a l so found 
that triparanol caused cholesterol reduction in rats aorta 
with a maximum accumulation of deposterol in brain, M&H-29 
has no c l i n i c a l value now a days due to toxic side ef fects 
(Wong e t a l . ,1966). 1-Dime thy 1-arainoe thy 1-4-benzyl-piperi dine 
(Iri 379) has been shown to possess hypolipidemic and anti-
atherosclerot ic properties (Q»Dell e t a l . , 1962),but Kottke 
e t a l . (1966) fa i l ed to confirm these properties in biros. 
Trans-1,4-bis (2-chlorobensylaminomethyl~<yclo-hexane-
diHCl (AY-9944) was shown to be a potent inhibitor of 
cholesterol synthesis (Chappel e t a l . , 1964y Hi l l , 1966 and 
Jones e t a l . , 1966). In almost a l l t i s sues especially serum 
and adrenal ft long term administration of the compound caused 
reduction in cholesterol l eve l s but 7-dehydrocholesterol 
accumulated in lungs. Therefore, i t i s quite l ikely that 
AY-9944 inhib i t s the conversion of 7-dehydrocholesterol to 
cholesterol (Dvornik and Hil l , 1968). Arnold at al.. (1966) 
1 a 
showed that l7-(3-hydroxy-l-propynyl)-3~»ethoxyestra-l, 3,5 
U0)-trien-l7P-ol-17*.hydroclnnaiiate(l§4P£) markedly reduced 
serum cholesterol in rats maintained on consnsrical laboratory 
feed, zt ha* estrogenic property. The estrogen* are know to 
possess hypocholesterolemic properties (Stamler et_ a l . , 1963). 
However, in the extensive studies of Borden e t ajL. (1964) 
rats given estradiol bensoate parenterally and forced-fed 
a high fat, low protein atherogenic diet responded with 
markedly elevated blood cholesterol levels . The ef fect of 
estrogen on l ip ids and protective e f fect on coronary athero-
sc l eros i s has been studied in cocJcrels (Clarke .et a l . ,1966), 
and in the cholesterol fed pigeon (Pr i t chard et a l . , 1966). 
Recently* Arnold e t e l . (1967) showed that m&S exerted hypo-
cholesterolemic e f fec t in rats fed high fat* low protein d ie t 
Cholestane-triol and i t s derivatives were found to lower 
(orally) blood and l i ver cholesterol and atherogenesls in 
cholesterol fed rabbits* while serum and l i v e r cholesterol 
were lowered in chickens and only the l i v e r cholesterol was 
lowered in rats (Aramakl e t a l . , 1967r Zmi e t a l . , 1967). 
I t has been shown that 2-raethoxy methyl-17 r\-methyl e s t radio. 
3-methylether (P-5780) exerts a hypocholesterolemic effect* 
Improves the plasma C/P ra t io and partly prevents the 
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accumulation of aort ic total l ip ids and cholesterol without 
any alga of eeterogenicity in both sexes of cholesterol-
cholata fed rats (HaJcanura J& ajL., 1965). Besides cholesterol, 
accumulation in aorta* l i var and adrenals and i improve men t in 
plasma c/P ratio, P-5780 did not suppress the incidence of 
coronary atherosclerosis and nypercholestetolemia in 
cholesterol ana corn o i l fed rabbits, ^orethylnoctred(2iBg/day; 
orally) was found to be an hypocholttsterolemic agent in 
cholesterol fed rabbits and w i able to reduce somewhat the 
aort ic atherosclerotic development (Gore e t a l . ,1967). 
Kritchevsky (1968) reported tnat the most popular estrogen 
preparation* premarln, a mixture of conjugated equine estrogens 
lowers the serum f> - l iproprotein and serum cholesterol levels . 
Although the mecnanism of action i s not clear* i t seems to 
involve a s h i f t of cholesterol from A to ^-l ipoproteins. 
Kstrogens have been shown to have a marked amdiorative effect 
on experimental atherosclerosis . The major dravjoack of 
estrogen therapy i s the frequently observed feminiamtion 
occuring in man. decently* aanaud (1970) studied the ef fect 
of premarln in preventing thrombosis & atherosclerosis in 
hyperlipemic rats , m fed rats an hyperlipemic diet with 
premarln (a or 12 mg/kg) upto 15 weeks. The two ooses were 
equally e f fec t ive in reducing the serum cholesterol and 
tr iglyceride l eve l s . Jbowever, the lower dosage was most 
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effect ive in prolonging coaguJLation and preventing thrombosis. 
The higher dosage was responsible for increased corticosterone 
level in plasma and decreased the serum albumin level , so 
among estrogens prams rin i s a bet ter fcypolipemic agent, 
several androsterone derivatives were reported as 
cholesterol inhibitors for a number of animal species 
(Singer e t a l . , 1959t Abell & Mosback, 1962; Holmes* 1964). 
however, the s i t e of action of these confounds remains to be 
established. A protein anabolic steroid 7 K^ -ethy*Vthio-17-
[b -hyaroay-17 ai. -methy 1-5 << -endrostane (3, 2-C) fyraxol 
[PS-179] has hypocholesterolemic and antiatherogenic properties 
UaKaraura e t a l . , 1967). This compouna has prophylatic e f fect 
on aort ic atherosclerosis* reduces t i s sue deposits and 
Improves the plasma non-esterif led fatty acids UJ£*A ) 
composition, a l so s l ight ly reduces the incidence of coronary 
atherosclerosis , conversely, i t was found inef fect ive on 
withdrawal of high fat feed i . e . af ter establishing hyper-
cholesterolemia. Later, Abell and Mosback (1968) observed a 
marked decrease in serum cholesterol l eve l with 17^-methyl-5 
^-androstane-3 / , 17/3-diol (a metabolite of 17<-methyltesto-
sterone) in dogs. It was a l so found that about 10 og/kg(orally) 
of e i ther parent compound or diol diminishes serum cholesterol 
l eve l by SOX. cortisone acetate has been shown to reduce 
the development of atherosclerosis in cholesterol-.fed 
rabbits by about 75% (Bailey and Butler* 1966), but fa i led 
to regress developed lesions* This Indicated that the 
action of the drug I s in the early stage of plaque formation 
through i t s anti-inflammatory properties rather than via 
any l ipenlc e f fec t s . 
A ser ies of thyroxine analogues have been synthesized 
and evaluated for hypocholesterolemic ac t iv i ty (Blank e£ a l . , 
1966).Kritchevsky and Tepper (1967 c) noted a severe 
reduction in atheroma in cholesterol-fed rabbits with 
©- thyroxine (0,5 mg/day) or L-thyroxine (0.05 ng/day). 
J> thyroxine a l so lovers serum cholesterol as well as 
/3-lipoproteins. The mechanism of i t s action i s not clear. 
However, there i s evidence from animal studies that thyroxine 
nay cause redistribution of cholesterol from serum into 
muscle and skin. 
A very promising method of lowering serum cholesterol 
appears in the b i l e acid sequestering agents. Cholestyramine* 
an ion-exchange resin original ly made available for re l i e f 
of bllary puritls* caused a dramatic reduction in serum 
cholesterol levels (ifeshim and Van Xtal l le , 1965). Beher e£ aj, . , 
(1967) reported that the compound prevented the t issue 
cholesterol accumulation in rats fed atherogenic diet* and 
do 
was e f fect ive in inhibiting atherosclerosis la rabbits, 
in a large number of patients constipation was the sloe 
e f fec t of cholestyramine, several otner agents which 
inhibi t absorption of cholesterol have ale© been studied 
as cholesterol lowering agents. Linoltxamide (*t-cyclohexyl~ 
linoleamide) e f fect ive ly reduced serum cholesterol/levels and 
severity of atherosclerosis in rabbits maintained on 
cholesterol diet i iatey e t a l . , 1966; outse l l and yuackenbush, 
1967;. Lino l e i c acid and i t s ethyl e s ter in cholesterol 
p 
containing diet have a l s o been shown to suppress the develop-
ment of atherosclerosis in various animals (Quidry and wu, 1966* 
Hutsell and Quackenbush, 1967). On the other handjft-cyclohexyL-
llnolearaide, while showing a good cholesterol lowering ef fect 
in cholesterol-*fed rabbits suppressed aort ic atherosclerotic 
plaque a t high doses (600 mg/day), and N-(K-raethylbenzyl-
linolearaide (MBLA) was more ef fect ive both ways(Kritchevsky 
and Tapper, 1967 d and Toki et a l . , 1967). Later, Fukushlma 
e t a l . (1969) compared the hypocholesterolemic act iv i ty of 
N-cyclone^ 1-1 inoleamide (CbLA), HBLA and /3 -s i s tero l . They 
noted that /?- s l s t e r o l has l e s ser ac t iv i ty than the former 
compounds, and the reduction of serum and l i v e r phospholipids, 
tr iglycerides and cholesterol was more with MB LA than CHIA. 
Or 
The inhibitory e f f ec t on experimental atherosclerosis 
w i in the orders 
D- MBIA? MBLA? L-MBIA 
decently another optical ly active 1-) &- [*< -phenyl-jB-
(k-tolyl) ethyl] linoleamide (PTIA) was found to have a 
remarkable hypocholesterolemlc e f f ec t in rabbits (Hakatani 
££ &!•# 1970). Administration of FiiA (5-10 rag/day/animal) 
a l s o s ignif icantly lowered serum and l i v e r cholesterol and 
prevented formation of aort ic atheromatous changes in 
rabbits that had been given 1.6g cholesterol daily. In 
r
~comparision to MBLA, PI LA showed a more pronounced l ip id 
lowering e f f e c t in cholesterol fed rabbits and severity of 
atherosclerosis was a l s o lowered markedly in FT LA treated 
than MB1A treated animals. 
Fisher e t a l . (1964) showed s igni f icant retardation 
in the developments of aor t i c les ions following the feeding 
of a diet containing citrus pectin without cholesterol 
supplementation in mature cocKrels. Pectin with cholesterol 
in the diet reduced blood cholesterol in rabbits and caused 
l e s s aort ic atherosclerosis without any e f f e c t on severity 
of coronary les ions (Fisher e t e l . , 1967). This suggested 
that pectin acts by accelerating the trans i t of food through 
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the alimentary t r a c t r e su l t ing in an increased excretion 
of poss ib le a therogenic substances as wel l a s of t o t a l 
n u t r i e n t s ( c a l o r i e s ) . Other agents which i n h i b i t absorption 
of choles te ro l have a l s o been studied a s choles tero l lowering 
agents . Daxtran and ce l lu lose when administered ora l ly ware 
a l s o show t o possess hypolipidemic p rope r t i e s in cock re la 
and dogs (Parkinson, 1967). Daxtran (6%, 30ml/day) given 
intravenously to choles te ro l - fed r abb i t s reduced the r i s e 
in serum choles te ro l , phospholipids and t r i g l y c e r i d e s , 
apparently due t o expansion of plasma volumes (Brahmanker 
and connor, 1967). Dsxtran-40 was a l s o found an t i a the ros -
c l e ro t i c in p a t i e n t s (Dl tzs l and uyeberg, 1969). Recently 
a new apparently nontoxic na tu ra l ly occuring ac id mucopoly-
saccharide from a mammalian source has been i so la t ed and 
pur i f ied , which has good l ipoprote in l i p a s e ac t iva t ing 
effects* The poly scene r ide , hepa r i t in sulphate has been 
shown to produce a reduction in serum choles te ro l l eve ls in 
rabb i t s fed a 2% cho les te ro l d i e t . I t a l s o reduced the 
formation of die tary induced atheroma in the a o r t i c wall of 
r abb i t s kept on a 2% cho les te ro l d i e t (Grossman e ^ a l . , 1 9 7 1 ) . 
CPIB, famil iar ly known a s c lo f ib ra t e was Introduced 
10 years ago for t reatment of hypcrlipidemia (Thorp and 
waring 1962, Atromid symposium, 1963). some important ac t ions 
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attributed to th is drug include inhibition of triglyceride 
release from l iver (Asarnof f at a l . , 1965r Mishkel and Webb, 
1967 and Gould et a l . , 1967), inhibition of hepatic cholesterol 
synthesis (Gould e t aJL., 1966) interference with lipoprotein 
synthesis (Gould e t a l . , 1967), inhibition of fatty acid 
synthesis (Maragoudakis, 1969), stimulation of lipoprotein 
l ipase ac t iv i ty in adipose t i ssue (Tolroan e t a l . , 1970), 
enhancement of tr iglyceride uptake by adipose t i ssue (Westel 
and Austin, 1968), stimulation of a deny 1 cyclase act iv i ty 
(Greene e_!§J,., 1970), and lowering of basal glycerol release 
from epididymal fa t (Carlson e t a l . ,1972). I t has a l so been 
found that the hypolipidemic action of cPZB i s dependent upon 
the nature and type of d iet (2akim and aerraan, 1969). 
Activity of a number of clofibrate analogues was 
described for use in the treatment of atherosclerosis , hass 
and Bancs* (1968) have reported a marked reduction in serum 
cholesterol and triglycerides of male rats receiving the new 
te tra l in phenoxy isobutyrate (CIBA, su-13437 or TP1A). In 
humans a reduction in serum triglycerides and to a l e s ser 
extent cholesterol and phospholipids was observed on the 
administration of su-13437(Best and Duncan, 1969). She most 
extensive study was tnat of ftartmantand For s tar (1969), who 
found that in 88 patients So-13437 was affect ive in reducing 
the serum triglycerides and cholesterol l e v e l s of Types III. 
IV and V hyperlipidemie while the Type II patients responded 
to a l e s ser degree, su-13437 was found more potent than 
do f ibra te (Best and Duncan, 1970). I t was ef fect ive and well 
tolerated compound with sustained hypolipidemic activeness. 
i&wever, a decrease of f ibr inolyt ic act iv i ty during the 
treatment was observed (Mannucci e& a l . ,1971) . in preliminary 
findings Berkowits (1969) reported that SaH 42-348, 1-methyl-
4-piperidyl b i s (p-chlorophenoxy) acetate was ef fect ive in 
reducing serum triglyceride and serum cholesterol. Timms e£ a l . . 
(1969) who worked with rats a l so found that th i s do f ibrate 
analogue was a more act ive hypolipidemic agent than the 
parent compound. Another important compound of th i s ser ies 
CDJB (potassium 2-methyl-2-[tp-chlorophenyl)-phenox^-propionate) 
has been reported to be an e f fec t ive hypolipidemic agent which 
does not cause l i v e r enlargement in rats (Leigh e t a l . . (1968) • 
control of Lipoaonoala - I t has been known for many years* 
that dietary and hormonal conditions may exert pronounced 
e f fect on l ipogenesls (Fritz. 1961; Masoro, 1962). Starvation, 
fat-feeding or diabetes, induced by the inject ion of alloxan, 
decrease hepatic fatty acid synthesis greatly(Bruggen e& a l . . 
1952; Modes e_fc a l . ,1952; Frit*, 1961; Whitney and Roberts. 1955; 
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and Brice and Okay, 1956). these results x*>re a l so confirmed 
with adipose t i ssue (Levei l le and «tenson, 19661 and Level l i e , 
1967a). riefeeding of starved animals restores fatty acid 
synthesis* If the ulet I s not high In fat , while l ipogenesis 
i s restored on giving Insulin to the alloxan uiabetic 
animals, in experiments with rat l iver extracts i t was 
found that fasting leads to a strong depression of acetyl COA 
carboxylase and to smaller oppression of fatty a d d synthetase 
U*usa e t al.. ,1961; Korchak and M*soro,1962). Similar findings 
were a l so obtained with diabetic rats (wieland *t a l . ,1963) 
as well as with rats fed on a fatty d iet (Borts f& a l . , 1963). 
On the other hand, the spec i f i c a c t i v i t i e s of both enzymes 
r i se to very high leve ls In l i v e r during high-carbohydrate, 
fat - free refeedlng of starved rats (QjCbson .et a l . , 1966). 
A marked Increase of long chain acyl COA under a l l 
conditions of depressed fatty acid synthesis was evident 
(sorts and Lynen, 1963; Tubbs and Garland, 1964 and fcieland 
e t a l . ,1965). A large number of enzymes have been shown to 
be inhibit*a by palmityl toA tttger-rteufelot e_fc a l . , 1965; 
TeJceta ana Pogell, 1966). 
The other regulating factor of acetyl COA carboxylase 
i s i t s activation by c i trate . Brady and Gurin (1952) f i r s t 
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observed that homogenate systems which incorporate acetate 
into long chain fatty acids required c i t ra te for optimum 
act iv i ty , vayelos e t aJL. (1963) clearly demonstrated that 
c i trate aa v e i l as other Krebs cycle intermediates 
(Gregolin e t al . ,1968) had a striking e f f e c t on the degree 
of aggregation of acetyl COA carboxylase. Tnere i s now 
evidence that the inhibitory action of acyl coVs i s related 
to disaggregation of act ive carboxylase trimer structure 
to the inactive monomers in the presence of acyl COA 
(Gregolin e t aJL., 1966,a,b,; tfuma e t al,. ,1966? and iieninger, 1969). 
It i s considered now that acyl CoA i s negative effector of 
acetyl COA carboxylase while xrebs cycle intermediates are 
pos i t ive modulators of t h i s enzyme. 
Citrate i s of course* primarily synthesized by c i trate 
synthetase from acetyl COA and oxaloacetic acid. This enzyme 
i s inhibited by long chain acyl COA thioesters (Tubbs, 1963; 
itileland end ttelss, 1963; wieland e t a l . #1964; and iynen afc a l . , 
1963). Moreover* c i trate cleavage enzyme primarily responsible 
for the breakdown of c i trate to acetyl COA and QAA* was found 
in low concentrations in starved rats and a t high concentrations 
in fed rats (Ball, 1966). decent work with a chloroplast 
fatty acid synthetase strongly suggests that* a t l eas t in plants, 
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a rate-l imiting step in the synthetase system my be a t 
ACP l a w l . But no evidence i s available concerning ths rols 
of acyl-ACP in regulating acetyl CoA carboy lass ac t iv i ty . 
Iner© i s a l so evidence that palmityl COA i s an obligatory 
intermediate in the transfer of palmityl groups from ACP 
to glycerol (Kuhn and Lynen, 1965). A quite different 
poss ib i l i ty , in view of the participation of ACP derivatives 
in fatty acid biosynthesis and of CoA esters in fatty acid 
oxidation* i s that an increase in the l eve l of acyl COA 
es ters rosy signal an increase in fat breakdown. At a time 
vhen the actions of hormonal and regulatory systems are 
causing the degradation of fats , i t i s appropriate that fat 
synthesis should be blocked. Conceivably th i s i s accomplished 
in part through inhibit ion of f i r s t step in l i p i d synthesis 
by long chain acyl COA esters , which are early intermediates 
in fat breakdown. It may well be not only ACP but also^ystems 
which remove long chain acyl COA thioesters such as t r i -
glyceride synthesizing systems would be additional partners 
responsible for the control of l i p i d synthesis in the c e l l . 
Lipids synthesis i s a l so increased above normal when 
the animals are on a high carbohydrate diet , the increase 
being especial ly large i f the starved animals art* iafed diet 
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high in carbohydrate and low in fat (Kornacker and 
IiOwensteln, 1965). Ihose changes which occur relatively 
slow are associated with al terat ions in t i s sue l eve l s of 
l ipogenlc enzymes, such adaptive phenomena are probably 
to be distinguished from short term e f fec t s of change of 
d iet in which rate control of l ipogenesls may be mediated 
through the action of modifiers on acetyl coA carboxylase 
(Jjowenstein, 1968). Furthermore, the rat io of sihWa/sAKW 
a l s o plays an important role in the control of l ipogenesls. 
hence a variety of enzymatic systems and dietary conditions 
are responsible for the control of l i p i d synthesis. 
The ac t iv i ty of both the lipogenic and g lyco lyt ic 
enzymes are important determinants of rate of hepatic fatty 
acid synthesis CfraKlm et ajL. ,1967r Ballard and hanson,1967; 
and 4iiH «t a l . ,1958). The a c t i v i t i e s of a number of 
hepatic enzymes are effected markedly by changes in the 
carbohydrate content of d iet (Tepperman and Tepperman, 1965; 
***** *& *£•• I960). Fasting, high fa t diets and high 
carbohydrate d ie t lead to paral le l changes in the act iv i ty 
of various hepatic enzymes including glucose-6-phosphate 
dehydrogenase, tfADP-malic enzyme and c i trate cleavage enzyme 
(Ball, 1966> Fitch and Chalkoff, 1960). Baldwin at a l . (1966) 
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showed that a c t i v i t i e s of various enzymes involved with 
firobden-Meyerhof pathway, *MP shunt and fat metabolism ware 
decreased by giving high fa t diets . Level l i e (1967a,b) 
showed the a c t i v i t i e s of glucose-6-phosphate dehydrogenase, 
malic ensyma, and 6-phosphogluconate dehydrogenase in l i ver 
as well as in adipose t i s sue were decreased by giving corn 
o i l diet to rats, tie a l so observed decrease in malic ensyma 
act iv i ty in adipose t i s sue of animals fed high protein diet 
which was low in carbohydrate along with l lpogenesls. The 
various nepatic ensymas a l so showed a pronounced adaptive 
behaviour toward hormonal influences lulaen, 1966; srere, 1965; 
Ballard and ban eon, 1967; Kornacker and Lowenstein, 1965; 
and Atkinson, 1969). 
It i s thought that the depression of ensyma a c t i v i t i e s 
during starvation i s due to the repression of ensyma 
synthesis. Thus the r i se in enzyme a c t i v i t i e s in animals 
under varying dietary conditions, v i s . , high carbohydrate, 
fat free re fee ding, could be explained as adaptive synthesis 
of new ensyma. &vioence supporting this view has emerged from 
studies of Gibson e t a l . (1966). As they found, speci f ic 
inhibitors of protein ay a thes is , such as puromycin and 
actinomycin D, injected into rats at the beginning of or 
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during the refeedlng period block the anticipated rise 
in the act iv i ty of acetyl COA carboxylase, fatty acid 
synthetase and c i trate cleavage enzyrae. 
The assumption that the changes in enzyme concentration 
are due to repression or induction of en*yrae synthesis i s 
further supported by experiments of Oellhorn and Benjamin 
(1966) with adipose t i ssue , who found that the rates of 
fatty acid production and their desaturation are reflected 
in the rates of JfosiA synthesis. That tnere i s a functional 
relationship between these events i s strongly suggested 
of 
by the fact tftat the restoration/H*A synthesis with refeedlng 
preceeds the repair of the fai lure in fatty acid synthesis. 
scope of th i s thes i s - Numerous physiological and non-
physiological lipid-lowering agents have been investigated 
but due to side e f fects their fate in the successful 
chemotherapy of atherosclerosis and a l l i e d diseases i s 
s t i l l debated. I t i s believed that any inhibitor of 
cholesterol biosynthesis acting prior to tt*J-CoA reductase 
(K C. 1 .1 .1 . 34) step, which i s considered to be the main 
regulatory point In hepatic cholesterologenesis(Siperstein 
and Fagan, 1966; Shapiro and aodwell, 1971) cannot be 
successfully used as hypocholesterolemic drug because i t 
would a lso e f fect other important metabolic reaction* 
of the body. 3-hydroxy~3-methylglutaridecid an anti-
metabolite of MVA for bacterial system (Wright. 1957) 
l a formed in vivo by deacylatlon of £M3-COA (Dekfcer 
e t a l . ,1958) and has been shown to Inhibit bacterial 
Mtt-COA reductase (Ilmognari and Rodwell, 1965), I t s 
possible Inhibitory e f fec t on hepatic iMS-CoA reductase 
i s evident from observations that *M3 decreases the 
conversion of acetate to mevalonate (Flmognarl* 1964) 
and inhib i t s the in vivo and in vitro incorporation of 
acetate but not mevalonate into cholesterol (Beg and 
Lupien, 1972). Earlier studies have indicated that 
£MS exerts a potent hypolipidemic action at relatively 
low doses and i s well tolerated in rats (Beg and siddiqi, 
1967* 1968). ULstopathologlcal studies a l so showed that 
IMS feeding to hypercholesterolemia rats did not bring 
any adverse e f fec t a t the ce l lu lar organisation of the 
t i ssue (Beg e t a l . . 1968). Recently Lupien e£ §1.(1973) 
reported that tMQ has a protective action on rabbits 
with experimental atherosclerosis . 
The present work i s directed to elucidate the 
hypolipidemic action of £M9 in normal and hypercholes-
terolemia rabbits. The e f fec t of prolonged administration 
of th i s compound on secure, l i v e r and aort ic l ip id* 
has been investigated in animals fad an atherogenic 
diet for 54 days. The in vitro and in vivo e f fec t 
of an on hepatic enzymes and i t s role in the 
regulation of fatty acid synthesis has a l so been 
studied to understand the e f fect of £M3 on various 
metabolic sy stems. 
* * * * * * * 
I I . E X P E R I M E N T A L 
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1. Materials 
Aninmls.* young male albino rabbit* wore purchased from 
the s toc* colony of a local supplier. For enzymatic studies 
an inbred strain of adult rale albino rats were obtained 
from the same local supplier. 
Diets» The animals were fed ad libitum on wind Lever 
Animals Feed (Hindustan Lever Ltd., India). For atherogenic 
d iet this basal diet was mixed with 2% cholesterol dispersed 
in 6% heated corn o i l (180° for 15 rain) as described by 
Kritchevsxy .ejfc a j . , (1961). 
Chemicals* special reagents obtained from commercial sources, 
used without further purification included! HMO and L-malic 
acid (Schwa rs/*tenn, U.S.A.); Kieselgel Q Jiach stahl, Trie 
(hydroxy methyl) aminoraethane and sodium pyruvate (E.Merk, 
Germany) ; dADP (mono sodium) and faMS (Sigma chemicals Co., U.S. A): 
mhD (reduced) and Qlucose-6-phosphate, disodium salt(B. a u$ 
London) i reference phospholipids. Oxaloacetic acid and tfAiii, 
(Biocnemicals Unit, V. P. chest Inst i tute , mini, inoia); 
sephadex G-200 and Blue dextran (Pharmacia, Sweden); OL-
l soc i t ra te , trisodium s a l t (Fluka, Switzerland) ; corn o i l 
(Anil starch Product Ltd., Ahemdabad, India); zeo-Karb 225 
(ion Exchange (India) Ltd., Bombay); and Acetate-l-<r (isotope 
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Division, Atomic energy establishment, Bombay), aest of 
the chemicals including cholesterol used were of analytical 
9rade. All solvents were dried and r e d i s t i l l e d before use. 
Glass d i s t i l l e d water was used throughout the study. 
2. chemical Methods 
Extraction of l ip ids from serum, l iver and aorta- Tissues 
were extracted for to ta l l ip ids by the method of Folch e t al, 
(1957) as modified by Misra (1963). Know amounts of serum 
(5-23 ml) from control and experimental rabbits ware 
transferred to 10 volumes of chloroform-methanol (2sl;v/v) 
and allowed to stand with occasional shaking a t room 
temperature for overnight* then f i l t ered . The residue was 
re-extract**a twice with 10 more voluuws of chloroform-
methanol for 2 hours a t room temperature and f i l tered. The 
f i l t r a t e s were pooled and evaporated to dryness in vacuum at 
40-50° in a rotary flask evaporator. 
The residue dissolved in chloroform-methanol solvent 
containing 4% water (v/v) was evaporated to dryness in 
vacuum a t 45-50°. This step was repeated twice to separate 
protein bound l ip ids . Tnis f ina l residue vea dissolved in 
chloroform-methanol mixture and f i l t ered . The f i l t r a t e was 
3 <3 
layered with 4 th volume of normal sal ine in a sejja rating 
funnel, gently mixed and allowed to stand a t room temperature 
unt i l the two phases separated clearly {4U6 hr). The lover 
chloroform-methanol layer was col lected. The upper layer 
washed twice with chloroform-methanol was pooled and 
evaporated to dryness again in vacuum a t the sane temperature. 
The dried resid£ was oissolved in a Known volume of 
chloroform. In case of l i v e r and aorta, the t i ssues were 
suspended in 25 ml of chloroform-methanol for over night. 
The t i s sues were removed from the chloroform-methanol mixture, 
grinded in mortar and pes t l e in chloroform-methanol. The 
slurry was transferred to another 10 volumes of chloroform-
methanol mixture. The mixtures were allowed to stand with 
occasional shaking a t room temperature for 4-6 hours. The 
l i p i d s were extracted as described for serum. 
Quantitative Determination of Total, iSsterifled and 
ffree Cholesterol - The method used was that of Bloor et e l . 
(1922). For serum cholesterol extraction a mixture of 
alcohols ether (3*l;v/v) was used. In about 25-30 ml Bloor* s 
alcohol-ether mixture taken in 100 ml g lass stoppered 
conical f lasks, known amount of serum was delivered drop by 
orop. The contents were constantly swirled to prevent 
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clumping of th« precipitate . The flask, was shaken 
vigorously for two minutes ana allowed to stand a t room 
temperature for one hour with occasional snaking. The 
contents were poured on to Whatman *io» 1 f i l t e r paper 
immediately covering the funnel with a watch glass*Known 
aliquot of Bloor's alcohols ether f 11 terete (5-10 ml) was 
transferred to a 50 ml dry beaker, evaporated almost to 
dryness on a steam bath* completing the to ta l evaporation 
of the solvent a t room temperature, About 3 ml of anhydrous 
chloroform was added to the residue, washing down the sides 
of tne beaker during the adoltlon. Tne contents were nee ted 
(boiling s t r i c t l y avoided)^ accented into 10 ml g lass 
stoppered stanoard flask* The extraction of the residue 
was repeated twice with 3 ml portion of chloroform and 
decanted into the same flask. The flask was cooled to room 
temperature and volume was made up to 10 ml mark with 
chloroform, transferred into a t e s t tube and corked. For 
to ta l cholesterol determination from l i p i d extract of serum, 
l i v e r or aorta, suitable aftquots were taken in a test-tube 
and made up the volume upto 10 ml with chloroform. 2 ml of 
colour reagent (ana pert concentrated sulfuric acid added 
slowly to 10 parts of l ea-co ld ace t i c anhyurlde) was added 
in each tub*. For reagent blank, a tub* containing 10 ml 
of anhydrous chloroform and 2 ml colour reagent was used. 
The tubes were kept in dark a t 25° for exactly 30 minutes. 
The developed green colour was read against reagent blank 
in AIMIL Biochem Absorptiomater using f i l t e r Ho. 70. Total 
cholesterol w s calculated from a calibration curve prepared 
by using aliquot* of pure cholesterol standard solutions 
(0 .0-2 .5 rag) in anhydrous chloroform. Under the described 
experimental conditions, 1.00 o. fit was equivalent to 2.0 rag 
cholesterol. 
For determination of e s ter cholesterol, another 
suitable aliquot of e i ther Bloor's alcohols ether f i l t r a t e 
or l i p i d extract was taken into a dry 50 ml beaker and one ml 
of l%(w/v) a lcohol ic oigitonin was added, mixed gently and 
evaporates to dryness. The residue was extracted twice with 
15 ml petroleum ether (40-60°). The petroleum ether extract 
was decanted into another dry 50 ml beaker. The combined 
extract was evaporated to dryness on a steam bath and the 
residue was extracted thrice with 3 ml of chloroform and made 
upto 10 ml. The e s ter i f l ed cholesterol so obtained was 
determined colorimetrically in the same manner as described 
for to ta l cholesterol . The difference between tota l and ester 
cholesterol gave the value of free cholesterol. 
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Quantitative Determination of Total Phospholipids- Total 
phospholipids were determined by the mathod of Bartletit(1959) 
as modified by Marinetti (1962). For direct determination 
from serum, 0 .1-0 ,5 ml serum was accurately delivered in 
centrifuge tubes containing 3 ml of water. 5 ml of freshly 
prepared 10% trichloroacet ic acid (w/v) solution was added. 
The tubes were allowed to stand for few minutes and centri-
fuge©, a t 3000 r.p.m, for 15 minutes. The supernatant was 
decanted and the tubes were inverted unt i l pract ical ly a l l 
the supernatant has been removed. For tota l phospholipids 
determination from l i p i d extract, a suitable aliquot was 
taken in a tube and evaporated to aryness. The contents of 
above centrifuge tubes or these tubes were digested on an 
e l e c t r i c digestion unit with 1ml of 70% perchloric acid for 
25-30 minutes (2-3 g lass beads or boi l ing chips were added 
in each tube to avoid bumping). On cooling 7 ml d i s t i l l e d 
water was added followed by 1.5ml of 2. 5% Ammonium Molybdate 
(w/v). The contents were mixed well and f inal ly 0.2ml of 0.25% 
purified andno-naptCthol sulfonic acid (ArtSA) reagent was 
added. The tubes were heated in a boi l ing water-bath for 
exactly 7 minutes, cooled ana the colour was read after 20 
minutes in AIMIL Biochem Absorptiometer (tfo, 70 f i l t er ) against 
A2 
a reagent blank. The calibration curve vas prepared similarly 
using monopotasslum olhyarogen phosphate as standard. It was 
found that 1.0, Q. i* w a equivalent t o 20 jug phosphorus. 3. he 
phospholipids values were obtained after multiplying the 
phospholipid phosphorus by a factor of 25. 
quantitative determination of Triglycerides - Total t r i -
glycerides were determined by the method of Van ton del and 
Zllversmlt (1957), 4 g &eokarb-225 was placed in a glass 
stoppered 100 ml conical f lask and 2 ml chloroform was added 
to i t . A suitable aliquot of serum or l i p i d extract of serum, 
l i v e r or aorta was added to i t and made up to 20 ml with 
chloroform, After one hour standing at room temperature 
(intermittent shaking was done), the contents were f i l t ered 
through a what nan *io. 1 f i l t e r paper. 1-3 ml aliquot of 
f i l t r a t e was transferred to three g lass stoppered tubes and 
solvent evaporated. To two tubes, 0. 5ml alcohol ic KOli was 
added, but 0.5ml alcohol was adoed to the third tube 
(unsaponified sample). All the tubes were kept at 60-70° for 
15 minutes. 0.5 ml of J.2W sulphuric a d d was added to each 
tube which were placed in a gently boi l ing water-bath for 
15 minutes to remove alcohol. After cooling glycerol content 
was determined by periodate oxidation. 0.1 ml 0.05M sodium 
periodate solution was added to the tubes and the oxidation 
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was stopped exactly af ter 10 minutes by adding 0.1 ml of 
j . 5M sooium arsenite. A yellow colour of iodine appeared 
which disappeared within few minutes. 9 ml of 0,2% 
chromotropic acid reagent (in sulphuric acid and water 
2»1, v/v) was added ana heated for exactly 30 minutes in 
boil ing water-bath, The colour was read in AIMIi, Biochem 
Absorptioraeter using f i l t e r no. 58. The quantity of glycerol 
was estimated by comparing against a standard curve of 
glycerol, i t was found that 1.00 O. a was equal t o J. 45 umoles 
of glycerol. The amount of tr iglyceride present was 
calculated by multiplying ju moles of glycerol obtained with 
900 (the average molecular weight of tr ig lycer ide) . 
3. Thin layer chromatography of Phospholipids 
^termination of Inoivictual Phospholipids - Using 
developing ana eluting solvents as described below* the 
individual phospholipids were separated by thin layer 
chromatography by the method of sXipsKi e t a l . (1964). 
(i) Preparation of Thin Layer Plates - Glass plates 
(20 x 20 cm) were washed thoroughly with chromic acid, tap 
water* detergent* and f ina l ly with g lass d i s t i l l e d water in 
sequence. These were then dried* wiped with a clean f i l t e r 
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paper and arranged horizontally end to end on a p las t i c 
support. 40g of Kleslgel 0 isiach stahl slurried with 90-92mi 
water were spread in 0. 5 ram thickness by an applicator in 
the usual manner (stahl, 19t2). The chronato-plates were 
allowed to cry in a i r unt i l the ge l became hard (1-2 hours) 
and stored in a dust free environment. The chromatoplates 
were activated at 110°-120° for one and half hour prior to 
the application of l i p i d samples. 
( i i ) Application of sample - The plates were cooled in a 
and 
desslcator/edges trimmed off excess s i l i c a ge l . To each 
chromatopiate a suitable aliquot of l i p i d extract and a 
mixture of reference l ip ids of known composition were applied 
as streaks (actually as a ser ies of extremely small over-
lapping spots) on the same chromatopiate. A l ine was drawn 
from top to bottom in the mi dale of the space between the 
streaks. Toe tota l amount of unknown phospholipids applied 
ranged 45-65 yUg. 
( l i i ) UBVei9Pn»nt 9 l OMromatograms - The development of 
chromatograms was performed in g lass tanks (250x250x120 mm). 
Jfiach tank was l ined with Whatman1 s chromatographic paper on 
three s iaes leaving aside the front face and the paper was 
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wetted with appropriate developing solvent. After tne 
saturation of the tan* with developing solvent Chloroform-
Methanol-water (65t25C4, v /v /v) , the plates were developed 
in ascending posit ion. After 40-50 minutes the solvent 
front moved to 18 cm from the bottom of the plate. 
(iv) ixatection of Phospholipids - The plates ware a ir 
driea for 10-20 minutes at room temperature. The streaks 
were detected by putting the plates in tank saturated with 
iodine vapours (Sims & Larose# 1962) and encircled with a 
fine needle. Iodine was allowed to fade in open atmosphere 
before removal of the streaks (a small amount of iodine 
did not interfere with the phosphorus determination). 40% 
(v/v) HgSOj spray reagent (Mangold* 1961) was a l so used in 
addition to iodine vapours t o detect the presence of l ip id 
material. 
(v) Removal of spots - The extra s i l i c a ge l unaer the 
ana above the solvent front was removed with the help of 
razor blade. The s i l i c a gel was scraped completely from 
each streak and trnasferred quantitatively to centrifuge 
tubes, TO ensure complete transfer of the material, the 
remaining periphery of the spot was scraped off the plate, 
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and the plate placed vert ica l ly and tapped to allow the 
scrapings to f a l l on glazed paper. The powder was combined 
with previously removed material, with the plate held so 
that the origin was on the bottom, a l l spots upto the centre 
of the plate were removed as described. The plate was then 
turned around and the same procedure was repeated beginning 
with tne solvent front and woriting tower us the mid-point of 
the plate . This procedure minimised the lo s s of phospho-
l i p i d s material, comparable areas containing no l i p i d spot, 
ware a l s o removed and served as control tubes. 
(vi) blutlon of Phospholipids - The individual phospholipids 
were eluted with H methanolic fld (Marlnettl, 1962). 5 ml 
of eluting solvent was added to each centrifuge tube. The 
tubes were placed in a water bath at 50-60° for 30 minutes 
st irring periodical ly with g lass rods and washing the glass 
rods with 2-3 ml of the solvent. The tubes ware then 
centrifuged for 15 minutes at 3000 r.p.m.and the supernatant 
was carefully decanted. The whole procedure was repeated 
once more and f inal ly the procedure was repeated with 3 ml 
of eluting solvent. The combined supernatant* ware evaporated 
to dryness in an oven a t 80-90° for over night or on e l ec t r i c 
digestion unit. 
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(vl i ) determination of Phospholipid Phosphorus» - The 
lturn phospholipid phosphorus was determined by modified 
method of Marinetti (1962) as described earl ier . 
*• snzymlc Studies 
Preparation of Liver jjomoaenaf - For determination of 
the enzymic a c t i v i t i e s l i v e r s of individual rats from each 
group were cut into small pieces and about l-3g from each 
l i v e r was homogenized in O.M Trls-tiCl buffer* pH 7.4 a t 
4° in a Potter-El vehjem homogenizer f i t t e d with Teflon pas t i e 
to give a 10?fr(w/v) homoganate. The horoogenate was cantrifuged 
at SOOxg at 4° for 10 min to remove c e l l debris. The super-
natant thus obtained was uaed in enzymes assay. 
Assay of finzymest - Measurements of extinction changes were 
carried out in calblometer fixed for 340 nm. The substrates 
were neutralised t o pu 7.4 prior t o use. The rates of changes 
in the extinction values were noted botn for period prior to 
tne addition of tne substrate as well as for the period of 
actual enzymic reaction following the audition of substrate. 
The net reaction rate was calculated from the difference 
between the two changes in extinction. All assays were 
4« 
performed under sero order kinet ics a t 28 + 2 (room 
temperature) la a reaction volume of 3.0 ml volume unless 
stated otherwise, 
glucose-6-phosphate dehydrogenase (D-glucose-6-phoaphatet 
fiiAi* oxldorectuotaser J4 C. 1.1.1.49) I t was assayed according 
to the procedure of shonk and Boxer (1964). iteaetlon mixture 
contained* aris-tfCl buffer, pfl 7. 4, 150 ju moles; MgClj, 10 u moles 
Qlucose~6~phosphatef 5 ;u moles, flAiaP, 0. 24 u moles and 0 .6-1 . 2ng 
enzyme protein. Increase in absorbancy at 340 nro was followed 
for 5 min. 
Lactate oehydroaenase (lr-lactate» *iAu oxidoreductase; 
ii. C. 1.1.1.27) . i t vies assayed according to Jtornberg (1955). 
She reaction mixture contained* T r i a - « d buffer, pH 7.4, 
150 u moles; Mg&2# 1 0 u ra°l««; sodium pyruvate, 5 u moles, 
AKbti, 0. 24 u molesr «na enzyme protein 4.0 - 6.0 ug. Decrease 
in absorbancy at 340 nm was followed for 5 min. 
Ma la te dehydrogenase (JU-malates K&D oxidoreductase; 
£.£. 1 .1 .1 . 37) - According to the procedure of Ochoa( 1948a) 
the reaction mixture contained* Tria-aci buf f er, pH 7. 4, 
100 u moles; oxaloecetate, 2.5 u moles; UADH, 0. 24 u moles; 
and 4.0 - 6.0 ug ensyme protein. Decrease in absorbancy at 
340 nm was followed for 5 min. 
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riAIJP-igocltrlc dehydrogenase {LB - i soc i trate t HhW 
oxldoreductase (dttcarboxylating); j£,a 1.1.1.42) - I t was 
assayed according to the method of Ochoa (1955). reaction 
mixture contained* Tris-HCi buffer, pH7.4 , 150 u molarMnClj, 
10 u moles; i soc i trate , 5 u moles; WADP, 0.24 u moles; and 
50>60 ug enzyme protein. Increase in absorbency at 340 nm 
was followed for 5 min. 
Ma la te dehydrogenase (decarboxylatina) - (Malic enzyme) 
IL-ma la te > tfAd? oxi do reductase (decarboxylatina) ; a, C. 1.1.1. 40)-
I t ves assayed according to the method described by Ochoa 
(1948b). reaction mixture contained! i r i s - i d buffer, pH 7, 4, 
100 u moles; Mncl2 10 u moles; L-malic acid, 5 u moles; OAi&, 
0. 24 u moles; and 0.6 - 1. 2 mg enzyme protein, increase in 
absorbency at 340 nm was recorded for 5 rain. 
Definition of Unit and spec i f ic ac t iv i ty ! 
One unit of the enzyme ac t iv i ty i s the amount of 
enzyme required to catalyze the formation of one ju mole 
HAW a or disappearance of one uraole of liADH par rain under 
the specif ied conditions, spec i f i c ac t iv i ty has been expressed 
in units per mg of enzyme protein. The extinction coefficients 
of the HADifH and suhDH 6. 22xlQ6<fcro2/mole was used to calculate 
enzyme units (uorecJcer and JCox~nberg, 1948). 
r — — , 
fluanUfr»Uy psSffrm^na^on, of ProW> o# j^vor qamoqenste - W» 
method used was essent ia l ly that of Lowxy •£ a l . (1951). In 
determining the protein concentration of the homogenate, 3.0 ml 
of 10% (w/v) TCA solution was added to 0,5 ml of rat l i v e r 
homogenate. The precipitate was centrifuged and supernatant 
discarded. The residue was successively washed thrice each 
with O.jyM potassium acetate In alcohol, alcohol, and ether. The 
washed precipitate was dissolved In 5.0 ml of O.Jji rtaOH by 
heating In a water bath. To a suitable al iquot (plus d i s t i l l e d 
water to make volume 1 ml) was added 5 ml copper reagent 
(prepared by mixing of 0.5% (w/v) copper sulphate In 1% (w/v) 
potassium tartarate and 2% (w/v) sodium carbonate In 0.V* NaOH 
In ltSO ratio) and the tubes Incubated at room temperature for 
10 rain. 0.5 ml of Folln-Clocalteau reagent (IN) was then added 
with brisk shaking. The colour intensity was read after 30 min. 
in AIM1L Biochem ifesorptlometer using red (Mo.70) f i l t e r , 
crysta l l ine bovine serum albumin was used as standard, 1.00 0. Ct 
was found equivalent to 0. 230 mg standard protein. 
5. Afiftaitf-ill-C14 incorporation fftudlos 
^ffQlaUon and mee,suremen% of rqdlOfcfrlLve fa^ty acids* 
For i sotopic studies the l i v e r was treated in a 
manner similar to that described by Cahlll e£ a l . (1959). 
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Th« t i s sue was rinsed in sal ine several t ines and transferred 
to a f lask containing 10 vol of chloroform-methenol solution 
12*1, v/v) and was extracted as described ear l ier for l ip ids . 
The l i p i d extract was washed twice by the method of Folch 
e t a l . (1957) to remove non lipio. radioactivity. After 
evaporation of the solvent under vacuum, the l ip ids were 
saponified by refluxing at 30 to 85° for 30 rain in 3% 
methanolic KOH (95 ml of methanol and 3g KOM in 5 ml water). 
Following saponification, the solution was diluted by the 
auaitlon of one-f i f th volume of water. The non saponifiable 
l i p i d s were removea by 3 successive extractions with 
petroleum ether 140-60°). The tota l saponifiable l ip ids 
ac id i f i ed with htil were partitioned between water and 
petroleum ether and the fatty acids removed by 3 successive 
extractions with petroleum ether (40-60°). The combined 
petroleum ether extract was back washed with water and 
evaporated t o dryness in a boil ing water bath. The residue 
was dissolved in ethanol, evaporated and redissolved in 
petroleum ether (40.60°) . Aliquots were transferred to 
pre weighed s ta in less s t e e l ' s planchets* solvent evaporated 
by infra red lamp and planchets were re-weighed. The radio-
ac t iv i ty of the sample was measured in G.M. counter to 
s t a t i s t i c a l s ignificance. 
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fc. Purification of Malic anzyms 
Isolation and part ial purification of rat l i v e r malic ensymet 
(a) Preparation of malic enzyme from l i v e r homoqenate» The 
method used was es sent ia l ly that of Frenkel 11971) described 
for bovine muscle, itet l i v e r s were obtained from freshly 
slaughtered animals* 50g fresh rat l i v e r was cut into pieces, 
connective and adipose t i s sue removed. The t i s sue was 
homogenised in a waring blender at 4° with 5 volumes of a 
solution containing 10mM Tris-Cl and IraM It-MXA, adjusted 
to pH 7. 5, a t high speed for 60 sec. The hoaogenate was 
centrifuged at 100,0 00 xg for 1 hr at 4° in a preparative 
ultra centrifuge, VAC-60. The supernatant f lu id was 
saturated with s o l i d ammonium sulphate in the proportion of 
17.6g/lQ0 ml of the solution to give a 0.30 saturated 
solution with respect to the sa l t . After st irring for 2 hr 
at 4° the suspension was centrifuged a t 1500303 for 40 rain. 
The precipitated protein was discarded ana the supernatant 
solution was adjusted to 0.75 saturation by addition of 8g 
of s o l i d ammonium sulphate to each ml of supernatant. After 
s t irr ing for 1 hr a t 4°, the precipitated protein was 
separated by centrifugatlon a t 1500 x g for 30 min and 
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dissolved in 50mM Tris-Cl-lmM /3-meroaptoethanol, pH 7.5. 
The resulting solution ves dialysed overnight against 50 
volumes of the same buffer at i f 
(*>) Chromatography on sephadex 0-200 - The dialysed 
solution resulting from the ammonium, sulphate fractionation 
vies chromatographed on a column (2.1x110 cm) of sephadex 
G-200 previously equilibrated with a buffer solution 
containing 50mM ' ir i s -c l and ImM /3-mercaptoethanol, pH 7.5. 
After the sample had been applied to the column, elutlon 
ides performed with the same buffer unt i l malic ensyme 
ac t iv i ty eluted from the column. This procedure removed 
most of the hemoglobin present in the protein fraction. 
Fractions of 5 ml were col lected and the malic ensyme 
ac t iv i ty assayed spectrophotometrically. 
* * * * * * * 
I M . & & S V L% 8 
5, 
Sff«ct of H*> treatment on serum l i p i d s of normal Jtebblts -
Two groups of young male albino rabbits, weighing about 
1. 25 tag were caged separately and fed basal diet and water 
ad libitum. The animals in the *M9-treated groups ware 
Injected lntraperitoneally 20 ng H40/kg/day in 2,5 ml 
d i s t i l l e d water for one week. The control group received 
2.5 a l d i s t i l l e d water only. At the end of the treatment/ 
the animals in both the groups were anaesthetised with ether, 
sacrif iced, and blood withdrawn by cardiac puncture, serum 
l i p i d s including Individual phospholipids were determined. 
The resul ts are summarised In Table I & II. 
The £M9 treatment caused s igni f icant lowering of serum 
tota l , e s t er l f l ed as well as free cholesterol, to ta l 
phospholipids and tr ig lycer ides . Besides these fcMQ also 
decreased the serum lyso lec i th ln , l ec i th in , sphingomyelin 
and cephalins fractions, ittwever, kMQ had no apparent side 
e f fec t on these animals. 
ere. 
T A B L & I 
SFF*CT Of IMO ON &&MJH LIPIflS OF aOflMAii-F&O HABBITS* 
Lipid parameter* control group OKI-treated Percent 
group Reduction 
Total c h o l e s t e r o l 
K s t e r i f i e d c h o l e s t e r o l 
Free c h o l e s t e r o l 
T r i g l y c e r i d e s 
Phospholipids 
160.00 + 6 .62 
119.00 + 5 . 2 0 
mm 
41.00 + 5.60 
108.86 + 9 . 2 8 






17. 7 0 c 
1 4 . 8 0 d 
3.60* 
9 . 7 0 b 






*Mean + standard error expressed in rag/100 ml serum for 
f i v e rabbi t s . 
S i g n i f i c a n t l y d i f f e r e n t from control , p 0 .001; Cp 0 . 0 1 ; 
dp<l0.02? * p < 0 . 0 5 . 
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I A B I S I I 
EFFECT OF Hi8 ON S&WM PHOSPHOLIPID FRAGTIQ S^ OF HOflH&L-FSP 
Phospholipid* control group H43-traatad Percent 
group induction 
Lyaolacithin 3 1 . 0 5 + 2.32 2 1 . 6 5 + 2 . 6 2 c 30 
Sphingomyelin 19.24 + 0 . 4 3 1 3 . 5 6 + 1 . 9 0 ° 29 
Leci thin 102.98 + 4.60 68 .95 + 8 . 5 0 b 33 
mm mm 
Caphalins 7.54 + 0.82 4.77 + 0 . 5 1 c 36 
* Maan + standard error expressed in ng/100 ml tenia for fiva 
rabbits. 
Significantly different from control, p < 0 . 0 1 ; C p 0.02. 
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affect °? *m op goyupt *4?»*r w$ APEU^ m*4*i 9t 
ttreerllpemlc rtabbif - Young male albino rabbits, weighing 
about 1-1.25 kg war* caged separately and wara given 
atherogenic diet of Kritchevsky o£ ejL. (1961) and water 
ad libitum. After f ive weeks the animals were divided into 
two groups with a balanced distribution of serum cholesterol 
l e v e l s among the groups* and the atherogenic diet was 
replaced by basal diet . The animals of *NO~treated group in 
addition to basal d iet received intraperitoneal inject ions 
of 20 mg tm per kg body weight per day in 2. 5 ml d i s t i l l e d 
water for varying periods. The animals in hyperlipemia 
put back 
control group/on basal diet received 2.5 ml water i . p . daily 
for the same period. The serum cholesterol and phospholipids 
ware checked af ter 5,10 and 14 days, tiach time blood samples 
(app. 2 ml) ware obtained from overniyht fasted animals by 
cardiac puncture. After two week of ma administration the 
animals ware anaesthetised with ether, sacrificed, and blood 
withdrawn by cardiac puncture. The l i v e r s ano aorta ware also 
removed Immediately, washed with normal saline, weighed and 
auspended in a mixture of chloroform-methanol (2$ 1, v/v) for 
l i p i d extraction. The resul ts shown in Tables III and IV 
have been obtained direct ly from serum. The data given in 
Tables V and VI have been obtained from the l i p i d extract of 
serum and aorta. 
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As shown in Table III , i*49 treatment for 3 days 
ins ignif icant ly decreased serum to ta l cholesterol and 
phospholipids by 13 and 20% , respectively. This decrease 
was more and more s igni f icant when iffS treatment was 
continued upto two weeks. After 10 days ***! aomlnistration, 
the decrease in serum cholesterol and phospholipids was 25 
and 30%, respectively, in addition, ma a l s o s ignif icantly 
reduced serum e s t r l f i e d cholesterol and triglycerides , 
however, a 35% but ins ignif icant reduction in free 
cholesterol was obtained (Table XV). **48 had no s ignif icant 
e f f ec t on l i v e r l i p i d s (Table not shown) whereas i t has 
marked e f f ec t on aorta to ta l cholesterol, tr ig lycerides and 
phospholipids. These parameters were decreased by 54,42, 
and 23* , respectively (Table V). An analysis of serum 
individual phospholipids shoWa marked decrease in cephalins 
fraction (54%) a l so reducing sphingomyelin, l ec i th in and 
cardiolipin to the extent of 39, 43 and 27%, respectively. 
However, a l i t t l e but ins igni f icant change (19)9 was 
observed in lyso lec i th in fraction (Table VI). 
59 
l A B L S I I I 
kSB&abiFmic coat SOL hup mj-immitD RABBIIS* 






3117 • 138 
3127 • 177 
Sfrypi PftOii?top^j.df «KlA°P «* 
Control 






1725 • 77 
1459 • 73 
13 
U . S . ) 
350 + 43 
686 + 87 
20 
1510 • 93 
1122 • 27 
25 
(p^.0 .05) 
623 + 64 
443 + 42 
30 
( p < 0 . 0 5 ) 
1436 + 80 
906 • 73 
37 
(P<0 .01 ) 
477 • 42 
283 • 44 
41 
(P<0 .01 ) 
* Mean 1 standard e r r o r expressed for f ive rabbits. 
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T A B L S IV 
jS&ittiM hlHD Vhib&S OF HTPaiiLIPiiMlC CUrfX RQJU &*fl tM^-'j KJ^ Al X^? 
BABBITS* 
i»ipid parameters itrperlipemlc &4S-treated percent 






1515 • 77 
1075 • 43 
440 • 84 
1071 • 192 
499 «• 14 
1006 • 7lb 
718 • 62* 
288 • I7d 
507 + 110c 






Mean + standard error expressea in my/100 ml serum for f i ve rabbits. 
Significantly different from control, p < 0 . 0 l ; 
c p < 0 . 0 5 ; d3i.s. 
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T A B U V 
AQigA LIVID VMAJ*S OF J&9*.Hk*lVi>MlC CQiVliOOL ArtP iMS-S JUATISQ flABBITS* 
Lipid parameters J=yperlipemic H4Q-treated percent 
control group group reduction 
Total c h o l e s t e r o l 1241 • 211 
Tr ig lycer ides 2591 + 1 1 2 
Phospholipids 956 + 100 
573 • 87c 
503 • 90b 




*Mean + standard error expressed in mg/lOOg wet aorta for f i v e 
rabbi t s . 
b S i g n i f l c a n t l y d i f f e r e n t from control , j^<0 .001; 
c p^.0 .02 j dw. & 
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l A B L i VI 
saauM PHOSPHOLIPID VAU^S OF afPiiajuiPiaac canaaoL A^D 
Phospholipids 3/perlipemie **4Q-tre«ted Percent 






80.6 + 3 .0 
128.8 + 4 . 5 
272.9 +14.0 
11. 2 • 2. 3 
3. 1 • 0# 5 
6 5 . 3 • 8 . 3 d 
79.0 + 2 . 3 b 
159.5 + 2 8 , 4 b 
5 .1 • 2 .0 C 






aHean ± standard error expressed in mg/100 ml serum for f ive 
rabbits. 
Significantly different from control, p O . O l r 
C P^0.05; dH.S. 
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The diet consumption was raor« or l e s s similar in the 
animals of both the groups. There was no l o s s in the body 
weight of the animals due to the a*3 treatment and the 
animals remained act ive throughout the investigation. 
JSffeet of Long-term MH Administration and simultaneous 
Feeding of Atherogenic d iet - Young male albino rabbits 
were caged separately and fed on the same atherogenic diet. 
After 10 days* serum cholesterol l e v e l s were determined and 
the animals divided into two groups in such a way that each 
group had balanced distribution of cholesterol, airing the 
following 54 days* the animals in each group ware fed athero-
genic diet and water ad. libitum . In audition, the animals 
of the HMO-treated group ware injected intraperitoneal]./ 
20 mg HMO/kg body weight/day in 2.5 ml d i s t i l l e d water. The 
paral le l control group received d i s t i l l e d water only, weekly 
serum tota l cholesterol and phospholipids were determined. 
After 54 days the animals ware anaesthetized with ether, blood 
withdrawn by cardiac puncture and serum obtained from over-
night fasted animals. Livers and aorta were removed Immediately 
washed with normal sal ine, weighed and suspended into a 
mixture of chloroform-methanol (2*1, v/v) for l i p i d extraction. 
Si 
The results are summarized in Tables VII, VIII, IX, X ,xi,& XII. 
The rise in the serum total cholesterol and phospholipids 
in the H43-treated group were always less than that of 
the parallel control group (Fig. 1 and 2). The triglycerides 
were 33* less in IMS-treated group after two weeks of 
administration (Controls 1616 • 28 mg% j IMS-treated 
1072 1 61 mg* ). 
H*3-treatment was* therefore, effective in resisting 
the rise in serum lipids (Table VII). It also checked the 
increase in liver cholesterol and triglycerides but had no 
effect on liver phospholipids (Table VZXZ). As compared to 
the parallel control group, treatment with IMS together with 
atherogenic diet did check the rise of aorta total, esterfied 
as well free cholesterol, triglycerides and phospholipids 
to the extent of 40, 43, 31, 50 and 28* , respectively 
(Table IX). As evident from Table X and XI £HS treatment 
resulted in marked decrease of various serum and aorta 
phospholipids fractions. It was of interest to note that 
serum cardiolipin was negligible in W«- treated animals as 
compared to atherogenic diet-fed control group (Table X). 
The body weight of the animals in the atherogenic diet fed 
group increased as compared to atherogenic diet fed plus 
f i g . 1 . affect of £M9 on serum cholesterol of 
atherogenic diet - fed rabbits (Mean values ' 
• s ignif icant ly different from control P< 0.< 
** P < 0 . 0 5 | *** P < 0.001 
See text for deta i l s . 
5 0 -
a 2 0 -
C l CONTROL GROUPS 
• I HMG-TREATED GROUPS 
BASE LINE 6 
Fig. 2, Affect of i*U on serum phospholipids of 
atherogenic diet- fed rabbit* (Mean values • S.a.M.) 
* Significantly different from control, p< 0.32; 
•* P<0.001f *** P<0 .01 
see text for detai l s . 
20r 
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y A a L a yti 
SMBm LIPID MALUSS OF JamROQMIC tXLSS F£D CQfflKflL 
AMP MJamOBdHlC JQI^C fiaifl PLUS k*Q-1 RcAl h.D BABBITS* 
Parameters Atherogenic diet Atherogenic Percent 
fed control d iet fed reduction 
group plus i*KJ-
treated group 
Total cholesterol 5857 + 744 3222 + 238b 45 
Sstei-fied cholesterolJ4419 • 607 2455 • 347c 44 
Free cholesterol 1438 + 1 0 2 767 + 7 l d 47 
Triglycerides 2819 + 419 1366 • 84G 52 
Phospholipids 1547 • 184 929 + 80b 40 
*Mean • standard error expressed in mg/100 nl serum for 
f ive rabbits. 
b Signif icant ly different from control, p < 0 . 0 1 ; 
c p < 0 . 0 2 ; *p< 0.001, 
1 A B L & VIII 
Liv&a LIPID VALU&S UF mmwsmic am* rm CUKIHUL 
AHP ATHaftUQjmiC igiSC ?&£> PUIS 0*3-1 RM*2*.D BABBITS* 
Parameters 
Total c h o l e s t e r o l 
S s t e r i f i e d 
c h o l e s t e r o l 
Free c h o l e s t e r o l 
T r i g l y c e r i d e s 
Phospholipids 
Atherogenic d i e t 
f ed control 
group 
8970 + 633 
5665 + 275 
3305 • 401 
1357 • 90 
3049 + 21 
Atherogenic 
d i e t fed p lus 
ttfO-treated 
group 
6556 • 482* 
4230 • 421 b 
2326 • 170 c 
806 • 121 d 








*Meen • standard error expressed i n mg/lOOg v e t l i v e r for 
f i v e rabbi t s , 
b. S i g n i f i c a n t l y d i f f e r e n t from contro l , p < 0 . 0 2 y 
c p < 0 . 0 5 > d p < 0 . 0 1 . 
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? A 8 I, g flfr 
A01BLA bIBID M S S OF AttflBitt»»>tIC flUSE *M> COIiaPi. 
AMP Alh^QQ^iC ui^l Fisi> PLUS £MG-riiWil&.U flABBIl'S* 
Parameters Atherogenic d i e t Atherogenic d i e t percent 
fed control fed p l u s IM3-treated reduction 
SL£OU£ W£Sm 
l o t a l c h o l e s t e r o l 3471 + 446 2101 • 198b 40 
£ s t e r i f i e d
 K 
c h o l e s t e r o l 2601 • 412 1507 • 123* 43 
Free c h o l e s t e r o l 357 • 91 594 + 8 5 b 31 
mm M» 
T r i g l y c e r i d e s 23993 + 1494 12201 • 86 3 C 50 
Phospholipids 1024 + 1 3 3 782 • 16 d 28 
*Mean + standard error expressed in rog/lOOg wet aorta for 
f i v e rabbi t s . 
s i g n i f i c a n t l y d i f f e r e n t from control , p 0 .05 ; 
c
 p^O.001* d p < 0 * 0 2 . 
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? A B L g X 
ggigJM PHOSPHOLIPID VALUES Of ATHS1WQEHIC DIJJT FED COmftQL 
AND Al'HSHOOatilC DIBT FED PLUS atg-TRSATSJP HABBB S* 
Phospholipids Atherogenic d i e t Atherogenic d i e t Percent 
Origin 
Lyso lec i tn in 
Sphingomyelin 
Lec i th in 
Cephalins 


















223. 4 • 




21. 2 £ 
21. 6 b 
26.7 C 
25. 2C 









*Mean + standard error expressed in ng/100 ml serum for f i v e 
rabbi t s . 
b S i g n i f i c a n t l y d i f f e r e n t from contro l , p < 0 . 0 2 
cp<:0.05> d p < 0 . 0 1 > • p < 0 . 0 0 1 > f t i .8. 
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y A B L ii jffi 
AORTA PHOSPHOLIPID VALUES OF ATHsaooa«ie o i a t r&o com-ROL 
AMD ATHJJ*»J5flIC SXLSS FfcP PLUS iKO-l EIKE*y> SABBZrs* 
Phospholipids Atherogenic d iet Atherogenic d iet Percent 















73.4 • 7.2 
73.8 • 4 . 1 b 
237.9 £11. 5* 
271.9 £21. 5C 








*Mean + standard error expressed in ng/lOOg wet aorta for 
f ive rabbits. 
b Signif icant ly different from control, p<0.01f 
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iM3-treated group (Table x l l ) . IMS a l so checked the 
l i v e r enlargement because the l iver of the atherogenic 
d iet fed plus i*«2-treated group (53*0 • 2.3a;) weighed 
13% ( p O . 0 5 ) l e s s than the atherogenic diet fed control 
group (61.0 + 2*4g). The increase in the body weight of 
the atherogenic d iet fed control group may* therefore, be 
due to the fatty l i v e r development and the deposition of 
more l i p i d s in the adipose t i s sues . Visual arbitrary 
grading of with and without stained aortas showed that the 
in 
animals/atherogenic diet - fed group had les ions of comparable 
severity in the aort ic arch and part of the thoracic aorta 
w i a l so involved but to a l e s s severe degree. These types 
of l es ions were almost absent from the animals of 
IMS-tree ted group. The degree of atherosclerosis can a lso 
be explained in terras of aorta cholesterol which was much 
lower in Ota- tree ted animals. 
* * * * * * * 
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a yuro Eflpw o# jf«? on gpfw fFtUc ^wwi of ffopn* 
f d Hats - s i x young male albino cats weighing 70-80g 
war* conditioned on JULnd Lavar animal faad and water ad 
libitum for one week. They vara k i l l e d by decapitation, 
l ivars removed immediately, washed and homogenized as 
described under "finsymic studies. " The resulting homoge-
nates were assayed for 0-6-P dehydrogenase, malic enzyme, 
NAOP-isocitric dehydrogenase, LDti, and HDH by the methods 
already described. Different concentrations of neutralized 
solution of H49 (pH 7.4) vera added to observe the in vitro 
af fect of i*4G. Zt was preincubated with enzyme in a 
buffered complete medium for 10 min at room temperature(30°). 
requisite substrates were than added to s tart the reaction 
as described under enzyme assay procedures. 
The resul ts presented in Table XIII show that the 
addition of different concentrations of km produced a marked 
decrease in malic enzyme ac t iv i ty . The ac t iv i ty was about 
23 and 35% lower with the additions of 23 and 50 umolas tt«4 
respectively. There was no affect on LDH and O-6-P dehydro-
genase even a t higher concentrations (upto 400 umolas) of 
JMO. On contrary tfAJDP-lsocitric dehydrogenase and HDH ware 





















































































































respectively. However, higher concentrations of IMS had 
no further e f fec t on these two enzymes. 
As shorn in Table XIV, the ac t iv i ty of malic enzyme 
f a l l s as the concentration of wa was increased. Under the 
experimental conditions the concentration of mi required 
to inhib i t the enzyme act iv i ty by 50* U ^ ) was 3». 2x10"T4. 
The decrease in the ac t iv i ty vats l inear when plotted 
against the log of inhibitor concentration (log l ) . Further-
more a p lot of the % Inhibition against inhibitor concen-
tration gave a sigmoidal curve suggesting that more than 
one molecule of the inhibitor was bound to the enzyme and 
these wore interacting. According to Bi l l equation 
(Hil l , 1913)$ 
log(v/Vmiix-v) - n log (S) - log k , 
i f l og (v /v -v) i s plotted against log I, a straight 
l i n e i s obtained (Fig. 3) . The slope of t h i s l ine , 1.7, i s 
the interaction coef f ic ient (n) which i s numerically equal 
to the number of Inhibitor binding s i t e s , when the inter-
actions are strong. This i s an experimentally accessible 
expression of the inhibit ion, where v i s the rate of reaction 
in the presence of inhibitor and I i s the concentration of 
the inhibitor. The value of n# numerically approaching 2, 
/ 
l A B I . f i XIV 
Ifl VITRU IflHIBITIOa OF MALIC JSHZYMJi BY tUG 









































*Mallc enryrae activity i s measured in the presence of 
£MQ at the concentrations indicated. 
T \"SSo 
3. fiffect of increasing concentrations of tf*3 on malic 
enzyme ac t iv i ty (Hil l Plot) . 
See text for detai l s . 
(ttttj concentrations of IMS 
v Activity of malic enzyme In presence of H43 
V
 v Activity of malic enzyme in absence of H43 
1.0 1.5 2.0 
logCHMGH 
2.5 
fig. 4. sigmoidal response of malic enaymeC crude) in presence 
of i#». 
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can be interpreted to mean that two molecule of inhibitor 
per substrate binding s i t e of malic enzyme ere involved in 
the inhibit ion, interactions of ma with the malate 
binding s i t e of the enzyme do not appear to be very 
strong as indicated by the high dissociation constant* 
K.« 41.96x10"" T*. Fig. 4 shows that the mechanism of malic 
enzyme inhibit ion by £M0 i s clearly a l l o s t e r i c . These results 
suggest that tm may act by controlling the leve l of NAtfPJi 
available for l ipogenesis , since HAD?a play a c r i t i c a l role in thi 
control of fatty acid synthesis. 
fti vivo affect of ma on flat Uver Bnzvmes -
U) The resul t s obtained from the experiment 
performed by injecting 10 mg iMS/rat/day in normal saline 
are presented in Table XV. I t i s evident that 7 days 
administration of ma to the normal fed rats lowered the 
act iv i ty of hepatic G-6-P dehydrogenase and malic enzyme 
by 19 and 25% , respectively. 
T h
« iE v*vo «f£«ct of ma on NAi*-isocitric 
dehydrogenase and LDH on the other hand* i s different. 
About 13% s ignif icant increase i s evident in the act iv i ty 
of these two enzymes. I t i s interesting to note that ma 
treatment fa i l ed to influence HDB. 
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T A B L E XV 









Malic enzyme 21.20+1.11 15.82*0.56 -25(p <~0.01) 
alucoee-6-
phosphate 
dehydrogenase 21.51+0.87 17.40+1. 10 -I9(p< 0.02) 
riAXft-Iaocitrlc 
dehydrogenase 242.30+10.8 273.9 +7.7 + 13(p<0.05) 
Lactic dehyoro-
genaae 1746.00+ 45 2109.00+ 93 +15(p< 0.01) 
Malic dehydro-
genase 2076.00+ 162 2079.00+9.9 
*Mean + standard error expressed for f ive rats. 
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(11) The data presented in Table XVI give the 
In vivo e f f ec t of H*3 on l i v e r enzymes of hypercholestero-
lemia rata* Two groups of young male albino rats weighing 
70-90g were fed a diet augmented with S% cholesterol for 
7 days with a simultaneous £MQ (10 rag/rat/day) treatment to 
the H43-treated group. The animals were decapitated without 
prior fasting at the termination of the experimental period. 
Although the food intake and changes in the to ta l body 
weight for the control and J**3-tree ted rats were nearly same* 
the rat io of l i v e r weight to whole body weight was greater 
in the control rats rather than in the treated animals.This 
i s in agreement with that of rabbits. I t has a lso been 
observed that the amount of protein per gram of l i v e r was 
s l ight ly higher in the IMS-treated animals. Under these 
conditions fcMS exhibits pronounced increase in the ac t iv i ty 
of malic enzyme, 3-6-P dehydrogenase, LDO, and MJ2& However, 
a l i t t l e but s ignif icant increase (llJd was a lso observed 
in the tfA&P-l s o d t r i e dehydrogenase, contrary to in vitro 
studies* the ac t iv i ty of malic enzyme i s considerably in-
creased (Table XVI). 
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T A B L t XVI 
IM VIVO AfFttCa.' OF iMP OK LIV&& &8iZWfiS OF iSPSaCHOL&SK SRPLaUC 
jeasynes s p e c i f i c a c t i v i t y Percent 














249. 50+2. 2 
2438.00+25 
2322.00+257 
23. 15+1. 20 
24.52+0.81 





11 (P< 0.001) 
25 (p<0 .01 ) 
6 0 ( p < 0 . 0 0 1 ) 
*Mean + standard error expressed for f i v e r a t s . 
8 4 
In Vivo affect of HCon Rat U w r gngymas meter Fasting 
( i ) The resul ts obtained from the experiment 
performed by injecting WW (lOmg/day/rat) in sal ine to 
tha fasting rata are shown in Table XVII. After 48 hr 
fasting and HM8-treatment* the animals were k i l l ed by 
decapitation and the 300 X g supernatant of 10% l i v e r 
homogenates were assyed for enzyme a c t i v i t i e s . The changes 
in to ta l body weight during fasting plus IMS treatment 
for both the groups were eiroller, however, the average 
l i v e r weight was s l i gh t ly high while the amount of 
protein per gram of l i v e r was s l ight ly low in the H«-
treated animals. 
airing starvation the ac t iv i ty of 0-6-P dehydrogenase 
and malic enzyme was decreased in the control group. H4S 
treatment exhibits a pronounced increase in the ac t iv i ty of 
these two enzymes with a very l i t t l e increase in the 
ac t iv i ty of wAi^-iaocitric denydrogenase and HDH. fcOwever, 
£MJ treatment fa i l ed to influence LDH under these conditions. 
These resul ts are suggestive of spec i f ic behaviour of HMB 
under different dietary s tress as i t did in cholesterol 
feeding animals. 
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t hB L & XV| | 









Malic i&zyme 8. 32+0. 47 13.024-0.87 57(p< 0.001) 
Glucose-6-Phos-




26. 07+1.60 42(p< 0.05) 
256.80+3.9 15(p<0 .01 ) 
Lact ic 
dehydrogenase 3246.00+134 3388.00+189 
Malic 
dehydrogenase 3000.00+150 3444.00+248 15(W.S.) 
*Mean + standard error expressed for five rats 
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( i i ) Two groups of young malt albino rata weighing 
80g, were fasted for 48 hr ana then refed with the normal 
basal d iet for 48 hr. During fasting and refeeding the 
animals of one group were given i . p . inject ions of iWG 
(lOmg/day/rat) in sal ine . The control group received saline 
only. After termination of experimental period* the animals 
were decapitated and l i v e r ensymes were assayed. The changes 
in the to ta l body weight and l i ver weight for both the groups 
were nearly similar, however, the amount of protein per gram 
of l i v e r was s l ight ly low in the it*3-treated group than that 
of the control group. 
As evident from labia 4VXXI, H*J treatment with 
simultaneous fasting and refeeding exhibits s ignif icant 
decrease in malic enzyme (32$4, Q-6-P dehydrogenase 141*), 
and Insignif icant decrease in MAiaP-isocitrlc dehydrogenase 
(830 and HOH (2090. aowever, there was no change in i,£tt 
ac t iv i ty . Under fasting and refeeding conditions induction 
and repression might play a role in influencing the l i v e r 
ensymes* 
ffffocfr of *f<Q on Acetfrte-E-S14 incorporation jlnfro Htpat^ic 
Itetty Acids of aormal-lad flats - Two groups of young male 
albino rats , weighing 75-100g (each group containing s i x rats) 
were fed basal diet and water a j libitum. The animals in the 
87 
y AB L S win 
IN VIVO £FFJSO.' OF AM3 CM hlY&A mZXH&S OF FASTgD-a*FJSP<48 hr) HATS 
enzymes s p e c i f i c a c t i v i t y Percent 






















32 (p<0 .05 ) 
4 l ( p < 0 . 0 5 ) 
8(tf .S.) 
mm 
20(8 .8 . ) 
a
 Mean + standard error expressed for f i v e r a t s . 
83 
fcMi-treated group received 15mg a43/day/rat in 1.0«d normal 
sa l ine for IS days. The control group received M M volume 
of sal ine daily. At the end of the treatment* the animal* 
of both the groups were given ace ta te - i - c 1 4 ( 50 uc i / rat in 
•aline) i . p . , 2 hr before sacr i f ice . Data were decapitated 
exactly after 2 hr individually* l i v e r s removed, washed 
several times with sal ine, blotted, weighed and suspended 
in chloroform-methanol (2*1, v/v) for fatty a d d s isolat ion 
according to the procedure already described earl ier , fatty 
acids were counted accordingly. I t i s clear from Table XIX, 
that in normal rats £M9 treatment s ignif icantly enhanced 
(120,* the ace ta te - l - c incorporation into hepatic fatty 
acids. 
Puyi^ca^on of to% frjveff, Majjc JSnsyme and ^n v ^ r o 
affect o f H Q o a Purified Malic snavme Activitvt 
SOg rat l i v e r were processed for malic enzyme purif i -
cation as described ear l ier . Fig. 5, shows the protein and 
ensymic ac t iv i ty pattern obtained during sephadex 0-200 
chromatography. As shown in Table xx, i t i s clear that about 
three fold enzyme purif ication has taken place, when th is 
^par t ia l ly) -
purified/malic enzyme was treated with ifO (50x10""TO,inte-
rest ingly, similar pattern of V vs S p lo t was obtained( f ig. 6) 
as with crude enzyme preparation. I t clearly demonstrates the 
a l l oat er i c Inhibition of malic enzyme in presence of £M9. 
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Y A B L & X** 
snscs or a o m %-as w vivo iacoa?QRttrioa OF AogCATft-i-c 
imo m&hiic FATTY ACIDS OF aojgtAL PUD HATS* 
14 
(3 roup Fatty acid (a.p.m./rag fatty acid) 
control 
» « - treated 
722 • 220 
1584 • 277 
Percent increase 120(p^Q.Q5) 
*Mean + standard error expressed for six rats* 
Fig. 5. sephadfcx O-200 chromatography of the soluble proteins 
of rat l i v e r sedimenting between 30-75% saturation of 
ammonium sulfate and possessing maximum malic enzyme 
act iv i ty . 
see text for deta i l s . 
•— Protein 
o—e Malic ensyme 
Size of the column 2.1x110 cm 
Flow rate 23 ral/hr 
volume of each fraction 5 ml 
700 
150 200 250 300 
Elution volume (ml ) 
350 
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T A B L E XX 
PURIFICATION OF MALIC WiVmn FROM 3AT LIVS* 
Fraction volume Protein Activity specific Purifi-
activity cation 
Cell free 100,00X0 
supernatant 
0. 30 Ammonium 
sulphate sa tu ra ted 
supernatant 
0. 30 t o 0.75 
Ammonium sulphate 
f rac t ion 
saphadex 3-200 

























A9*6. sigraoidal responaa of malic aniyma (part ial ly purlfiad) 
in presence of HHS. 








* D I S C U S S I O N 
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murtloaal studies 
Last decade has seen a rapid growth in the under-
standing of the et iology and machanica o£ atherosclerosis. 
Various dietary measures along with the usa of drugs can 
bring serum l i p i d l e v e l s to a "normal* value and with these 
measures, a considerable majority of coronary heart disease 
and atherosclerosis can be prevented. Thia i i seased state 
i s associated with increased lipoprotein concentration 
which could be the resul t of e i ther Increased release or 
decreased removal from plasma* in relation to the normal 
s tate . The causes of hyperllpidemias are l i t t l e understood 
and there i s divergence of opinions whether the release 
of very low density l ipoproteins into the plasma i s Increased 
or the removal i s defective. I t i s not known whether 
increased fatty acid and cholesterol biosynthesis can lead 
to elevated plasma l ipoproteins in man and animals although 
genetical ly obese animals which have high lipogenic capacity 
are a l so hyperlipidemic (Maragoudakls et a l . , 1972). 
The resul ts of present Investigation show that an 
exerts a profound hypolipidemic e f fec t in the normal as well 
as in the cholesterol fed rabbit* as has been shown ear l ier 
in rats (Beg and siddiqi , 1967; 1968). Thus the l i p i d lowering 
action of H4G does not appear to be species-specif ic . 
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As shown In Tobias X and II , IMS treatment 
s ignif icant ly decreases serum tota l cholesterol, e s ter 
cholesterol , phospholipids and tr iglycerides in normally-
fed rabbits* Among phospholipids the decrease was more-or-
l e s s evenly distributed among the various fractions but 
with a s l ight ly greater trend with cephalins. However, ma 
treatment for one weefc produced no s ignif icant ef fect on 
hepatic l i p i d s (data not given). 
Almost a l l serum and aort ic l i p i d s vera s ignif icantly 
reduced in hypercholesterolemia animals two weeks after 
return to normal basal diet followed by H43 treatment 
(Tables III* IV and V) • A s ignif icant decrease in serum 
lec i th in , sphingomyelin and cephalins i s a l so evident 
(Table VI). These resul ts suggest that ma, in addition to 
a l lev iat ing hyperlipemia, reverses l i p i d deposition in the 
aorta, a property considered essent ia l for the successful 
therapy of disorders associated with hypercholesterolemia 
(Douglas, 1970). The decrease observed in almost a l l l i p i d 
fractions strongly suggests an e f f ec t on serum lipoproteins. 
I t has long been recognised that the efficacy of medical 
approaches to atherosclerosis can best be evaluated in long 
terra atuaies. The resul t s described in Tables VII to XII 
provide evidence of the potential of £M8 in resist ing rise of 
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various lipid parameters in serum, liver and aorta whan 
given along with cholesterol-corn oil diet for 54 days. Tigs. 1 
and 2 clearly demonstrate that HO did significantly check 
the rise in serum cholesterol and phospholipids. In these 
regressive studies* IMS markedly suppressed the elevation of 
serum* liver and aortic triglycerides and cholesterol. Almost 
all serum and aortic phospholipid fractions* ware 
significantly lover but strikingly so with serum cardiolipin 
in IMS- treated animals. There « t no effect on aortic 
sphingomyelin. These results show that IM9 could effectively 
counteract the enhanced lipemic response to dietary 
cholesterol**corn oil combination and does not produce any 
toxic effects. 
It is premature to suggest the mechanism of action of 
mo. i&wever* as all serum lipid fractions are affected the 
action seems likely to be on lipoproteins. Moreover* 
reduction was most marked in triglycerides in all experiments 
suggesting an inhibition of triglycerides formation in 
liver and hence an effect on VLDL and LDL. In addition* the 
fall in serum triglyceride levels occured in the absence of 
a rise in hepatic triglyceride concentrations. This suggests 
that inhibition of hepatic formation of triglycerides* rather 
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than assembly of l ipoprotein complex** or their release, 
may bo the i n i t i a l mechanism by which IMS inhibi ts 
tr ig lycerides output from l iver , tiowsver, data do not 
exclude an additional e f f ec t of t h i s agent on lipoprotein 
synthesis* assembly or release which nay contribute to or 
maintain a hypotriglycerideralc e f fec t . The reduction in 
fatty acid es ter i f i ca t ion may a l so account for the inhibition 
of tr iglyceride formation. In addition to inhibiting 
cholesterol synthesis (Fimognari, 1964; Beg and Lupien, 1972), 
H49 interferes at some stage of fatty acid synthesis as 
reported for CFXB and CIBA (Maragoudakls, 1969). The 
Inhibition of hepatic tr iglyceride output could be attributed 
to suppress fatty acid synthesis or es ter i f i cat ion , decreased 
lipoprotein formation, or a reduction in release of 
l ipoproteins from l iver . However* these experiments do not 
rule out an e f fec t of M*3 at the l eve l of absorption and 
degradation of l ip ids . 
The a b i l i t y of H43 to lower a l l the l i p i d parameters 
i s of special importance* since elevation in these biochemical 
parameters have been reported as characterist ic of Individuals 
suffering from coronary heart disease (Qertler and white, 1954). 
I t has a l so been reported that cholesterol i s a major 
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constituent of atherosclerotic lesion (Fronts and Moore, 1969). 
It is also well established that the accumulation of 
cholesterol in aorta parallels remarkably wall with the level 
of cholesterol found in the serum (Nichols e£ al.« 1971). 
Furthermore, there is correlation between the severity of 
atherosclerosis and high levels of cholesterol and tri-
glycerides in aorta. It is now wall documented that tri-
glycerides rather than cholesterol play critical role in 
the etiology of atherosclerosis (schilling e£ al., 1966; 
ohirardi e£ al.«1972). 
of 
ttarller Bay (1962) suggested a role/phosphollpids in 
the development of aort ic less ion because i t s distribution 
was similar to those of cholesterol and neutral lipids* 
Peeters j& a l . (1970) a l so bel ieved that the structure of 
phospholipids may play a role in the s tab i l i ty of l ipoproteins 
and their interaction with the arter ia l wall since the 
cholesterol to phospholipids rat io i s generally considered 
to be an index of atherogenecity. Cholesterol i s supposed 
to be incorporated into the c e l l s of les ion as cholesterol-
phospholipids droplet* the cholesterol becoming es ter i f l ed 
within the c e l l and transformed into amorphous droplets of 
cholestryl es ters (waller e t a l . , 1968) . Furthermore* 
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the presence of led thin-cholesterol transacylase in the 
arterial veil provides evidence for the esterlflcetion of 
cholesterol in aorta since only free cholesterol rather 
than esterified cholesterol is exchanged with the blood 
during atherosclerosis. Redaction In the levels of 
cephalins and sphingomyelin due to 4MQ treatment may also 
possibly decrease the chances of atherosclerosis since high 
concentrations of these parameters are evident in the 
aortas and plasmas of diseased monkeys (Portman and 
Alexander* 1970) and in the peripheral occlusive arterial 
disease (Kunx and stummvoll, 1971), respectively, 
Aecently, Lupien et al. (1973) reported the antihyper-
lipemic and antiatherosclerotic properties of IMS in rabbits. 
They believed that the mechanism of action of this compound 
in Inhibiting the development of atherosclerosis might 
Involve a shift in lipoprotein spectrum which may also 
partially be responsible for decreased cholesterol deposition 
in liver. They suggested that in reducing serum cholesterol, 
an increased rate of excretion of cholesterol and/or its 
metabolite can not possibly be excluded. The effect of H4G 
upon rate of fecal excretion of steroids and turnover of 
bile acids and lipoprotein metabolism has been postulated by 
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these worxers. Except for hepatic phospholipids* a l l l ip id 
l e v e l s were s ignif icant ly lower in the IMS-treated animals 
(Table VIII). Moreover, recent studies of saleemuddin and 
Siddiqi (1972) have show that H43 acts in a physiological 
control mechanism for cholesterol synthesis. 
flnzynvlc studies 
Besides acetyl COA carboxylase, Q-6-P dehydrogenase, 
malic enzyme and fiiADF-isoeltric dehydrogenase play 
c r i t i c a l l y Important role in the l ipogenesis . some lipogenic 
and g lyco ly t i c enzymes as possible locus of action of fM3 
have been investigated, msymic analyses under variety of 
nutrit ional conditions provide some insight into the 
mechanism of hypolipidemic action of H43. Addition of 
different concentrations of H48 produced a merited depression 
in malic enzyme ac t iv i ty . The a c t i v i t i e s of LQH and 0-6-P 
dehydrogenase were not affected by km even at higher 
concentrations. However, similar doses produce enhancement 
in the a c t i v i t i e s of HDti and tfA£P-i s o d t r i e dehydrogenase 
(Table XIII). The inhibit ion of malic enzyme i s quite 
speci f ic , s ince the higher doses of £MS drastical ly inhibited 
t h i s enzyme (Table XIV). Moreover?, k inet ic studies with crude 
as wall part ia l ly purified enzyme preparations showed that 
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fMQ behave* a l l o s t er i ca l l y ( f i g s . 4 and 6) . The probable 
molecular order of participation of £N3 in the inhibition of 
rat l i v e r malic enzyme was obtained by the i&ll p lot (Fig. 3) 
where interaction coef f ic ient ia approximately two. i t is* 
therefore, quite probable that binding of two fcMG molecules 
per act ive s i t e was suf f ic ient for inactivation. However* 
interactions of mi with the malate binding s i t e of the 
enzyme may not be so strong as shown by the high dissociation 
constant* K± * 41.96x10"*M. The significance of th i s 
observation i s ye t to be investigated with more purified 
enzyme. 
The malic enzyme and G-6-P dehydrogenase a c t i v i t i e s were 
s ignif icantly lowered but HASP-isocitrie dehydrogenase and LBH 
were s ignif icantly increased when normally fed rats received 
i . p inject ion of IMS (Table XV). The decrease in the act iv i ty 
of malic enzyme and O-6-P dehydrogenase appears to be an 
expected biochemical e f fect of H*3 which lowers the l i p i d 
contents of the blood (Tables Z and XX). The hypolipidemic 
act iv i ty of the compound could have, been exerted by reducing 
or controlling the HADPH available for l lpogenesls since 
NADFty'tfAJDP rat io i s known to play a c r i t i c a l role in the fatty 
acid synthesis. 
Lipid synthesis i s depressed on fat feeding and fasting 
(Borts e t a l . , 1963; wieland e£ aJL.*1963). Various l i v e r enzymes 
including G-6-P dehydrogenase, malic enzyme and c i trate 
cleavage enzyme show a pronounced adaptive behaviour 
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towards hormonal influences and varied feeding conditions. 
The a c t i v i t i e s of these ensymes change in paral le l with 
the extent of Upogenesls (Olsen, 1966; Ballard and Sanson, 
1967). The pyruvate carboxylaae-malate dehydrogenase-malic 
enzyme system represents an ATP-requiring trans-hydrogenstlon 
and can account for the transfer of the reducing equivalents 
(LiADH formed during the conversion of glucose to pyruvate 
via JSmbden-Meyerhof pathway) Into NAUPH suitable for Upo-
genesls (Ball, 1966). since «40 Inhibits malic ensyme and 
a l so o-6-P dehydrogenase l e s s NADPH I S available for l lpo-
genesls and the HADM formed during laabden-Meyerhof pathway 
brings about an Increase In the ac t iv i ty of hDH. The 
observed Increase in the tfAUP-iaocitric dehydrogenase activity 
could be responsible for decreasing c i trate concentration 
which in turn may diminish fatty a d d synthesis through 
lnactlvatlon of acetyl COA carboxylase. 
The mechanism Involved In the reduction of ensyraatic 
and Upogenlc ac t iv i ty on fa t feeding was not clear for 
long, several reports have demonstrated that diet Induced 
Increase in o-e-P dehydrogenase ac t iv i ty are dependent upon 
the simultaneous Ingestion of the carbohydrate and protein 
(Nlemeyer e£ §1., 1962r Pi tot e& §J.., 1964; Me Donald and 
J vj ij 
Johnson, 1965). A c r i t i c a l l i terature survey supports 
another conclusion that, the changes in the act iv i ty of 
G-6-P dehydrogenase and malic ensyme are secondary to 
a l terat ions which increase the metabolic demand for reducing 
equivalents in the form of NADPH. Thus in fasting-refeeding 
the increase in O-6-P dehydrogenase and malic enzyme 
act iv i ty i s preceded by an Increase in lipogenesis (Teppermai 
and Tepperman, 1964). The increase in 0-6-P dehydrogenase 
observed in animals refed a high carbohydrate diet following 
a fas t (2akim e t a l , , 1967) can be explained on the basis 
of increased demand for MAOPfi to support the increase in 
l ipogenesis . 
The proposed mechanism i s consistent with the 
decreased enzyme act iv i ty in IMS-treated normally fed rats 
with a resulting decrease in the oxidation of tiADPti which 
could in turn trigger a reduction in 0-6-P dehydrogenase 
and malic ensyme ac t iv i ty , such a mechanism i s in kwping 
with present concepts concerning the homeostatic control 
of l ipogenesis and related requirements for reduced 
coenzymes (Levell le, 1966), 
in 5% cholesterol f«d rats (Table an) 1*3 treatroen 
brings about a s ignif icant increase in the ac t iv i t i e s of 
malic ensyme (85Jw. G-6-P dehydrogenase (S3tf, nm <60*>, 
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LDH (25!w and KAflB-isocitric dehydrogenase (11*). i t i s 
interesting to note that under t h i s condition of 
nutrit ional s tress the a c t i v i t i e s of malic enzyme and 
0-6-P dehydrogenase i s brought a t par with the normal 
fed control rats (Table XV). The reason for increase in 
the a c t i v i t i e s of LDbi. MDH and NA£P-isocltric dehydrogenase 
may be same as stated for normal fed rats. 
A very large number of ensymes a c t i v i t i e s are 
s ignif icantly decreased under condition of starvation 
(rreedland, 1967) • I t i s not certain why the systems 
behave in th i s fashion but several p o s s i b i l i t i e s ex is t , 
the f i r s t poss ib i l i ty i s a large scale change in the 
internal nutrit ion of the rats* the second poss ib i l i ty 
i s the s tab i l i ty of the template or ra-rttfA which may decay 
without replenishment as there i s evidence that certain 
ra-tiNAs may have l i fe-span rather than a h a l f - l i f e 
(Pitot , 1965). There i s a l so poss ib i l i ty of change in 
hormone balance for i t has been shown that certain ensymes 
in starved rats decrease more rapidly in rats with various 
endocrine removals than in normal rats (Weber, 1963) and 
again the s ta b i l i t y of the turnover time of certain enzymes 
may be altered s ignif icantly during starve tlon(s}iimke, 1964). 
1 n <; 
JL O -i 
The a c t i v i t i e s of the enzymes thought to be indirectly 
involved in l ipogenesis were the l e a s t stable. This may 
("reflect the absence of l ipogenesis during starvation. 
Therefore* 0-o-P dehydrogenase and malic enzyme a c t i v i t i e s 
are decreased in fasted rats. *M3 treatment causes a 
s ignif icant increase in malic enzyme (57?0* G-6-P dehydro-
genase 142*} and ftAUP-isocltric dehydrogenase (15?d while 
the increase in LDH and MDH a c t i v i t i e s were not s t a t i s t i -
cal ly s ignif icant. I t could* therefore* be assumed that 
*i«3 i s capable of correcting the large scale starvation 
induced change in internal nutrition of the rats. 
Mien ma treatment was extended to the fasted rats 
with the refeeding of a normal basal diet s ignif icant 
depression in the ac t iv i ty of malic enzyme and 0-6-P 
dehydrogenase was found (Table XXX). The other enzymes 
tested were not influenced by *M3 treatment under fasting-
refeeding condition. This could be due to actual changes 
in enzyme content rather than activation or inhibition of 
preformed enzyme. Thus* in l i v e r the rate of enzyme 
synthesis or degradation could a lso be related to explain 
the mechanism of action of ma. The enhancement of malic 
enzyme and O-6-P dehydrogenase due to fcMGi treatment in 
cholesterol fed and fasted rats (where as compared to 
105 
normally-fed animals* Table XV, the depression in the 
ac t iv i ty of these enzymes occur) possible role of 
degradation and synthesis of more ensymes can ^ be 
excluded. 
Numerous other factors may influence the act iv i ty 
of acetyl COA carboxylase* malic enzyme* Q-6-F dehydro-
genase, c i trate cleavage ensyme in vivo. Availability of 
Krebs cycle intermediate (Atkinson* 1969) * inhibition ty 
long chain acyl COA compounds (Borts and Lynen, 1963) and 
other as ye t unkno-wn factors* could a lso be related to 
these complex processes in vivo. 
Recently, roles of synthesis and degradation as 
determinants of the l e v e l s of certain lipogenic and 
g lyco ly t i c ensymes have been investigated in the l i vers 
of rats subjected to various nutrit ional s tates . Craig e l a_l. 
(1972) have shown that the dramatic Increase in l eve l s of 
hepatic fatty acid synthetase upon refeeding a fat-free 
diet i s due to an increase in the rate of de novo synthesis 
of the enzyme. 
In addition to the fatty acid synthetase a number of 
other enzymes have been shosjn to exhibit similar changes 
in act iv i ty with a paral le l change in hepatic lipogenesis 
in response to nutrit ional s tress . Among these are acetyl 
...... O 'O 
COA carboxylase (Allmann «t aj^., 1965; Muto and Gibson, 1970), 
c i trate cleavage enzyme (Kornacker and LOwenstein, 1965; 
Muto and Qlbson, 1970) and malic enzyme (Tepperman and 
Tepperraan, 1964; Muto and Gibson, 1970). A stimulation 
in malic enzyme upon refeeding a fat- free diet haa bean 
reported by Lyons and Gibson (1971). I t appears, therefore, 
that tha rata of enzyme aynthaaia i a an important parameter 
in controlling tha l e v e l s of theae enzymes aa well as that 
of fatty acid synthetase in l iver . Thus, tha synthesis of 
these enzymes which are essent ial for the synthesis of 
fatty acids may ba coordinataly controlled* a mechanism 
which mould obviously ba of benefit to tha organism. This 
conclusion i s further supported by tha findings of Muto 
and Gibson (1970) that tha greatly stimulated a c t i v i t i e s 
of tha lipoganic enzymes* namely* acetyl COA carboxylase, 
fatty acid synthetase, c i trate cleavage enzyme, malic 
enzyme and G-6-P dehydrogenase in the l i v e r s of rats 
maintained on a fat - free diet are progressively diminished 
on oral administration of polyunsaturated fatty acids. 
These results a l so suggest that polyunsaturated fatty acids 
are responsible for such adaptive changea in lipogenlc 
enzymes. 
In contrast to synthesis* degradation of enxymes 
also play important role in the control processes. Fatty acid 
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seems to be degraded more rapidly in the fasted state 
than in the normal and refed s ta tes (Craig e t a l . , 1972), 
The degradation of other enzymes has been reported to 
increase in the fasted state as in acetyl COA carboxylase 
(Nakanishl and wuma, 1970}f and malic enzyme (silpananta 
and Qoodrldge, 1971). in general* the degradation of 
to ta l soluble l i v e r proteins i s increased on starvation. 
Unlike ms other hypolipidemic agent v i z , , clofibrate 
(Zakim e£ al . ,1970) and CIBA (schacht and Qranzer, 1970) 
increased the ac t iv i ty of malic enzyme under normal 
feeding conditions. These compounds were inhibitory to 
acetyl COA carboxylase in vi tro and in vivo (Maragoudakis, 
1969; Maragoudakis e t a l . , 1972) however* IMS i s only 
inhibitory to acetyl COA carboxylase at higher concentrations 
(Beg( Z.&, personal communication), therefore, hypolipide-
mic act iv i ty of £MQ could not be explained on the basis of 
acetyl COA carboxylase inhibit ion. 
CIBA induced increase in malic enzyme appears to be 
an incomprehnsible biochemical e f fec t of a druge which 
lowers the l i p i d contents of blood and l i v e r (schacht and 
Qranzer, 1970). This has been explained on the basis of 
approximately equal act iv i ty increase of microsomal NADPH-
cytochrome c reductase. This microsomal enzyme complex 
10 S 
oxidises the hydrogen of AKQPH with atmospheric oxygen 
to water, no ATP being formed. Through an ATP-dependent 
reaction which runs between pyruvate, GAA and malate, 
hydrogen nay be transferred from HAUti to i«AOPii(seubert and 
Huth, 1965; Kornacxer and Lowenstein, 1965) and i t s 
oxidation f inal ly achieved by alcrosonal tfADPB- cytochrome c 
reductase. In t h i s reaction cycle malic enzyme catalyses 
the third and l a s t reaction, the a*A»-dependent oxidative 
decarboxylation of malate to pyruvate, iMujea being formed. 
Therefore, l ike CXBA, th i s complex type of enzyme mediatian 
may not possibly be ruled out in case of *M3 treatment to 
cholesterol fed ana fasted rate in which act iv i ty of malic 
ensyme and G-6-? dehydrogenase i s increasing, further the 
enhancement of acetate-1-c incorporation into hepatic 
fatty acids (Table xix) of normally fed rats i s an 
incomprehensible biochemical e f fec t of hypolipidemic action 
of *M3. This type of synergist ic result has a l so been 
reported with CPIB (Avoy «£ 3±> * 1965) • Thus acceleration 
of fatty acid degradation could a lso be one of the 
possible way to explain the hypolipidemic action of tf*3. 
Our studies suggest that i#*3 has a great potential 
as hypolipidemic drug; i t i s e f fec t ive in both short and 
long-term administration. The role of tr iglycerides , 
10S 
phospholipids and cholesterol in atherogenesis is wall 
documented (schilling at al., 1965; Qhirardi e£ al., 1972; 
Peeters et al. ,1970; Waller et al., 1968) M49 treatment 
lowers all these fractions. As » » la a natural 
metabolite (Delcker et al. ,1958), it is well tolerated 
and does not produce any side effects. Malic enzyme and 
G-6-P dehyarogenase are considered important determinants 
of the rate of hepatic fatty acid synthesis (2aJtlm et al., 
1967; Ballard and Hanson, 1967; Cahill e& §1., 1958) and 
Mi inhibits in vitro and £n vivo malic enzyme activity 
and in vivo G-6-P dehydrogenase activity. Moreover* recent 
studies from this laboratory have shown that HMQ acts in 
a physiological control mechanism for cholesterol 
synthesis (Saleemuddin and slddiqi, 1972). 
****** 
V. S U M M A R Y 
110 
itfperchol©steroleraia and hyperlipidemia are prelude 
to atherosclerosis . 3-i#droxy-3-raethylglutaric add* a 
known hypolipidemic agent for rats* a l so s ignif icantly 
decreased aacum cholesterol* phospholipid* and triglycaridas 
of normally-fed rabbits* furthermore* ••rum lec i th in , 
sphingomyelin and eaphalins were a l so lowered signif icantly. 
In hypercholesterol amic rabbits transfsrrad to basal diat 
similar rasults wara obtained in serum and aorta on tM3 
administration. Serum, l i v e r and aort ic cholesterol, 
triglycaridas and phospholipids were strikingly low in Un-
treated rabbits simultaneously fad an atherogenic diet . 
Among serum and aorta phospholipid fractions in long-terra 
atherogenic diat-fad rabbits eaphalins wara maximally lowarad. 
The dacraasa observed in almost a l l l i p i d fractions strongly 
suggests an affact on serum lipoproteins. Among l i p i d 
parameters triglycaridas ware markedly decreased in a l l experi-
ments suggesting an inhibit ion of tr ig lycerides formation in 
l i v e r and hence an affact on VLJ3L and LDL. furthermore, the 
f a l l in ssrum triglycarida l e v e l s occurred in the absence of 
r i s e in hepatic triglycarida concentrations. Therefore, i t 
appaars that inhibit ion of hepatic formation of triglycaridas* 
rather than assembly of lipoprotein complexes or their release 
may be the i n i t i a l mechanism by which i§«3 inhib i t s triglyceride* 
ill 
output from l iver . However, an additional e f fect on 
lipoprotein synthesis, assembly or release may not possibly 
be ruled out. An e f fec t a t the l eve l of l i p i d absorption 
and degradation may be a l so possible . Higher concentrations 
of sphingomyelin and cephallns are a l so belived to be an 
index of atherogenecity. Therefore, their reduction along with 
other phospholipid fractions suggests a role of fits, in 
addition to a l lev iat ing hyperlipemia, on the reduction of 
l i p i d deposition in aorta and other t i s sues . 
under varying dietary s tress , in vivo and in vitro 
ef fect of mi on hepatic ensymes clearly demonstrates i t s 
interference with fatty acid synthesis besides cholesterol 
and tr iglycerides . Jj£ vi tro BIS lowered the malic ensyme 
act iv i ty and th is inhibit ion seems to be a l l o s t e r i c with both 
crude and part ia l ly purif ied ensyme preparations. The 
significance of th i s observation i s ye t to be investigated 
with more purified ensyme. in normal-fed and in fasted-refed 
rats both malic ensyme and glucose-6~ phosphate dehydrogenase 
a c t i v i t i e s were s ignif icantly lowered on ma administration, 
since malic ensyme and glucos«-6~phosphate dehydrogenase are 
considered to be the better determinants of fatty acids 
synthesis, the hypolipidemic action of JM3 coul£ have been 
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exerted by con trol l ing the NAfiPH available for l ipogenesis. 
The in vi tro and in vivo increase, observed in iiADP-i s o d t r i e 
dehydrogenase activity* under varying diatary conditions 
could alao be responsible for decreasing c i trata concantration 
which in turn may diminish fatty acid aynthssia through 
inactivation of acetyl OOA carboxylase. 
In cholesterol-fed rats *M3 traatmant brings about a 
pronouncad increase in malic enzyme* glucose-6-phosphate 
dehydrogenase* malic dehydrogenase* l a c t i c dahydroganaaa and 
HASP-isocl t r i e dehydrogenase. All thaaa enzymes increased in 
fastad rats except l a c t i c dahydroganaaa and malic dehydrogenase 
which did not raapond to H43 traatmant, Tha incraasa in 
enzyme ac t iv i t i aa in both conditions appears to ba an 
lncomprahansibla biochemical o f f se t of IMS which lovers l ip id 
content in blood and l ivar . i t could* therefore, ba assumad 
that MMQ i s capable of correcting tha large seals starvation 
induced changes in internal nutrition of the animals. To 
explain the enhancement of malic ensyme and glucose-6-phosphate 
dehydrogenase a c t i v i t i e s on Ha? administration in cholesterol 
fed rata, tha poss ible role of degradation and syntheaie of 
more ensyme cannot be excluded. The enhancement of acetate-
incorporation into hepatic fatty acids of normally-fed rats 
1 *1 <r> 
i s again an incomprehensible biochemical e f fec t of *M3. 
Tha accalaratlon of fatty acid degradation could alao ba 
one of tha possible way a to explain tha hypolipidemic 
action of JM9. 
Our studies suggest that H43 has a great potantial aa 
hypolipidemic drugs i t l a affactiva in both ahort and 
long-tarn administration. I t could* 
(I) inh ib i t cholaatarol aynthaaia and triglyceridaa 
formation and i t a output from l lvar . 
(II) inhib i t l ipoprotein synthesis? thair aaaambly and 
raductlon in thair ralaaaa from l lvar, 
( i l l ) possibly affact on absorption and degradation of 
l ipids. 
(iv) inh ib i t malic enzyme in vivo aa wall aa in vitro 
but glucoso-phosphata dehydrogenase act iv i ty £a vivo 
only. 
(v) incraasa NAD*-isocitrie danydrogenasa act iv i ty 
causing l a s s avai labi l i ty of c i trate for acetyl COA 
carboxylase activation and hence indirectly lower 
tha rata of fatty a d d aynthaaia. 
(vi) accelerate fatty a d d degradation. 
(v l i ) possibly affact on degradation and synthesis of 
malic ensyme and glueose-6-phosphate dehydrogenase. 
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